<PAGE>
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement [_] CONFIDENTIAL, FOR USE OF THE
COMMISSION ONLY (AS PERMITTED BY
RULE 14A-6(E)(2))
[X] Definitive Proxy Statement
[_] Definitive Additional Materials
[_] Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12
Advanced Technology Laboratories, Inc.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2)
or Item 22(a)(2) of Schedule 14A.
[_] $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3).
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
-------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
-------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
-------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
-------------------------------------------------------------------------
(5) Total fee paid:
-------------------------------------------------------------------------
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
-------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
-------------------------------------------------------------------------
(3) Filing Party:
-------------------------------------------------------------------------
(4) Date Filed:
-------------------------------------------------------------------------
Notes:
<PAGE>
LOGO
Advanced Technology Laboratories, Inc.
22100 Bothell-Everett Highway
P.O. Box 3003
Bothell, WA 98041-3003
April 1, 1996
Dear Shareholder:
You are cordially invited to attend the 1996 Annual General Meeting of
Shareholders of Advanced Technology Laboratories, Inc., at 9:30 a.m. on
Wednesday, May 8, 1996, at the Four Seasons Olympic Hotel, 411 University
Street, Seattle, Washington 98101.
At the Annual General Meeting, shareholders will be asked to elect directors
to the Board of Directors, to consider and vote upon proposed amendments to
the Company's shareholder approved stock option plans, and to ratify the
appointment of KPMG Peat Marwick as independent auditors for the Company for
1996.
The Notice of Meeting and Proxy Statement on the following pages describe in
detail the matters to be presented at the meeting.
Whether or not you plan to attend the meeting, we hope you will have your
stock represented by signing, dating and returning your proxy card in the
enclosed envelope as soon as possible. Your stock will be voted in accordance
with the instructions you have given in your proxy. You may, of course, attend
the Annual General Meeting and vote in person even if you have previously
returned your proxy card.
Sincerely,
/s/ Dennis C. Fill
Dennis C. Fill
Chairman and
Chief Executive Officer
IMPORTANT
A Proxy Statement and proxy card are enclosed. All shareholders are urged
to complete and mail the proxy promptly. The enclosed envelope for return of
the proxy card requires no postage. Any shareholder attending the meeting
may personally vote on all matters which are considered, in which event the
signed proxy is revoked.
IT IS IMPORTANT THAT YOUR STOCK BE VOTED.
<PAGE>
LOGO [Advanced Technology Laboratories, Inc.]
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
MAY 8, 1996
To our Shareholders:
The Annual General Meeting of Shareholders of Advanced Technology
Laboratories, Inc. will be held at 9:30 a.m. on Wednesday, May 8, 1996, at the
Four Seasons Olympic Hotel, 411 University Street, Seattle, Washington 98101,
for the following purposes:
1. To elect seven Directors to hold office until the next Annual General
Meeting of Shareholders and until their respective successors are
elected and qualified;
2. To consider and vote upon a proposal to increase the shares of ATL
Common Stock available for issuance under the Amended 1992 Option, Stock
Appreciation Right, Restricted Stock, Stock Grant and Performance Unit
Plan;
3. To consider and vote upon a proposal to increase the shares of ATL
Common Stock available for issuance under the Amended Nonemployee
Director Stock Option Plan;
4. To ratify the appointment of KPMG Peat Marwick, LLP as its independent
auditors for 1996; and
5. To transact such other business as may properly come before the meeting.
The Board of Directors has fixed March 18, 1996 as the record date for the
determination of shareholders entitled to receive notice of and to vote at the
Annual General Meeting or any adjournment thereof. Only shareholders of record
at the close of business on that date will be entitled to notice of and to
vote at the meeting.
ALL SHAREHOLDERS ARE INVITED TO ATTEND THE MEETING IN PERSON, BUT EVEN IF
YOU EXPECT TO BE PRESENT AT THE MEETING, YOU ARE REQUESTED TO MARK, DATE, SIGN
AND RETURN THE ENCLOSED PROXY CARD AS PROMPTLY AS POSSIBLE IN THE POSTAGE-PAID
ENVELOPE PROVIDED TO ENSURE YOUR REPRESENTATION. SHAREHOLDERS ATTENDING THE
MEETING MAY VOTE IN PERSON EVEN IF THEY HAVE PREVIOUSLY SENT IN A PROXY.
By Order of the Board of Directors
/s/ W. Brinton Yorks, Jr.
W. Brinton Yorks, Jr.
Secretary
Bothell, Washington
April 1, 1996
<PAGE>
PROXY STATEMENT
ADVANCED TECHNOLOGY LABORATORIES, INC.
ANNUAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON WEDNESDAY, MAY 8, 1996
GENERAL
The enclosed proxy is solicited by the Board of Directors of Advanced
Technology Laboratories, Inc. ("ATL" or the "Company"), for use at the Annual
General Meeting of Shareholders (the "Annual Meeting") to be held at 9:30 a.m.
on Wednesday, May 8, 1996, at the Four Seasons Olympic Hotel, 411 University
Street, Seattle, Washington 98101, and at any adjournment thereof.
The address of the principal executive offices of ATL is 22100 Bothell
Everett Highway, P.O. Box 3003, Bothell, WA 98041-3003.
This Proxy Statement and the accompanying proxy card are being mailed to ATL
shareholders on or about April 1, 1996.
OUTSTANDING SECURITIES AND VOTING RIGHTS
Only holders of record of ATL's common stock, par value $0.01 per share (the
"Common Stock"), at the close of business on March 18, 1996, will be entitled
to vote at the Annual Meeting. On that date, the Company had outstanding
13,882,178 shares of Common Stock, which had a closing price of $26.50 as
reported on the Nasdaq Stock Market. Each share of Common Stock is entitled to
one vote at the Annual Meeting. The presence in person or by proxy of the
holders of record of one-third of the outstanding shares of Common Stock
issued and outstanding and entitled to vote is required to constitute a quorum
for the transaction of business at the meeting. Abstentions and broker non-
votes will be considered represented at the meeting for the purpose of
determining a quorum.
Under Washington law and the Company's Articles of Incorporation, if a
quorum is present at the meeting: (i) the seven nominees for election to the
Board of Directors who receive the largest number of votes cast for the
election of Directors by the shares present in person or represented by proxy
at the meeting and entitled to vote shall be elected Directors, and (ii) each
of the other matters listed in the accompanying Notice of Annual General
Meeting of Shareholders must be approved by the affirmative vote of a majority
of the shares present in person or represented by proxy at the meeting and
entitled to vote at the Annual Meeting. Abstention and broker nonvotes will
have no effect on the election of Directors. Abstention from voting will have
the practical effect of voting against any of the other matters since it is
one less vote for approval. Broker nonvotes on one or more matters will have
no impact on such matters since they are not considered "shares present" for
voting purposes.
PROXY VOTING
Shares for which proxies are properly executed and returned will be voted at
the meeting in accordance with the directions noted thereon, and in the
absence of directions to the contrary, such shares will be voted: "FOR" the
election of the nominees for the Board of Directors named in the following
pages, "FOR" the proposal to amend the Amended 1992 Option, Stock Appreciation
Right, Restricted Stock, Stock Grant and Performance Unit Plan (the "1992
Plan"), "FOR" the proposal to amend the Amended Nonemployee Director Stock
Option Plan (the "Director Plan") and "FOR" the ratification of the
appointment of KPMG Peat Marwick as independent auditors for the Company for
1996. It is not expected that any matters other than those referred to in the
Proxy Statement will be brought before the Annual Meeting. If, however, other
matters are properly presented, the persons named as proxies will vote in
accordance with their judgment with respect to such matters. The grant of a
proxy will also confer discretionary authority on the persons named in the
proxy to vote on matters incident to the conduct of the Annual Meeting.
1
<PAGE>
REVOCATION
Any shareholder giving a proxy may revoke it at any time before it is voted
by delivering to the Secretary of the Company a written notice of revocation
or a duly executed proxy bearing a later date, or by attending the meeting and
electing to vote in person.
PROPOSAL 1: ELECTION OF DIRECTORS
In accordance with the Bylaws of the Company, the Board of Directors has
fixed the number of Directors constituting the Board at seven, each to hold
office for a term of one year and until his successor shall have been elected
and qualified. Kirby L. Cramer, Harvey Feigenbaum, Dennis C. Fill, Eugene A.
Larson, John R. Miller, Phillip M. Nudelman, and Harry Woolf have been
nominated for election to the Board of Directors for 1996. It is intended that
votes will be cast pursuant to the accompanying proxy for the election of
these nominees, each of whom is at present a Director of the Company, unless
contrary instructions are received. If any nominee should become unavailable
for any reason, it is intended that votes will be cast for a substitute
nominee designated by the Board. The Board has no reason to believe that the
nominees named will be unable to serve if elected.
Biographical information regarding each of the nominees for the Board of
Directors is set forth below:
KIRBY L. CRAMER. Mr. Cramer (age 59) has served as a Director since February
26, 1993. Mr. Cramer serves as Chairman of the Compensation Committee and is a
member of the Audit Committee. Mr. Cramer is the Chairman Emeritus of Hazleton
Laboratories Corporation, a contract biological and chemical research
laboratory, which was acquired by Corning Incorporated in 1987. He is Chairman
of the Board of Northwestern Trust Company and also President of Keystone
Capital Company, an investment company. Mr. Cramer received his Bachelor of
Arts degree from Northwestern University and Master of Business Administration
degree from the University of Washington and is a graduate of the Harvard
Business School's Advanced Management Program. In 1988, he received an
honorary Doctor of Laws degree from James Madison University. Mr. Cramer is a
member of the University of Washington Foundation and also is Chairman of the
Advisory Board of the University of Washington School of Business
Administration. He is the past President and Trustee Emeritus of the Darden
School Foundation of the University of Virginia. Mr. Cramer is a member of the
boards of directors of Northwestern Trust Company, Immunex Corporation, Unilab
Corporation, The Commerce Bank of Washington, N.A., Landec Corporation,
Applied Bioscience International and International Technology Corp.
HARVEY FEIGENBAUM, M.D. Dr. Feigenbaum (age 62) has served as a Director
since January 2, 1987. He is Chairman of the Audit Committee and is a member
ATL's Scientific Advisory Board. Dr. Feigenbaum has been a Distinguished
Professor of Medicine at the Indiana University Medical Center since 1980,
joining its faculty in 1962. He was elected to Phi Beta Kappa and received a
Bachelor's degree summa cum laude from Indiana University in 1955, an M.D.
from the Indiana School of Medicine in 1958, and his Cardiovascular
Subspecialty, American Board of Internal Medicine in 1969. Dr. Feigenbaum is a
fellow of the American College of Physicians, the American College of
Cardiology, the Council on Clinical Cardiology of the American Heart
Association and the American Institute of Ultrasound in Medicine, as well as a
member of the Editorial Boards of the American Heart Journal, the American
Journal of Cardiology and the journal Circulation. He is the editor of the
Journal of the American Society of Echocardiography. Dr. Feigenbaum is a
director of Regentrief Foundation for Delivery of Healthcare and SpaceLabs
Medical, Inc.
DENNIS C. FILL. Mr. Fill (age 66) has served as a Director, Chairman of the
Board and Chief Executive Officer of ATL and as a member of the Executive
Committee of ATL since November 11, 1986. From 1978 through mid-December 1986,
he served as a member of the board of directors of Squibb Corporation (the
former parent of ATL) and as its President and Chief Operating Officer. Mr.
Fill attended Ealing College, the Institute of Export and Borough Polytechnic.
He also served in the Royal Air Force. Mr. Fill is a member of the boards of
directors of Beckman Instruments, Inc., Morton International, Inc., SpaceLabs
Medical, Inc. and Cytran, Inc.
2
<PAGE>
EUGENE A. LARSON. Mr. Larson (age 53) has served as a Director and a member
of ATL's Scientific Advisory Board since December 22, 1992, as a member of the
Executive Committee since May 5, 1993, and is a member of the Audit Committee.
Mr. Larson previously served as a Director and President of ATL from June 1988
to January 1990. He has served as a consultant to ATL since January 1993. From
January 1991 to December 1992, he served as Executive Vice President of ATL.
Mr. Larson also served as a consultant to Westmark and ATL in 1987 and 1990,
and as ATL's Vice President, Technology from February 1988 to June 1988. He
was Professor of Entrepreneurship and Innovation, Department of Engineering,
Pennsylvania State University in 1986 and 1987. Mr. Larson was founder and
President of Echo Ultrasound, Inc., a manufacturer of medical ultrasound
devices, which was acquired by Johnson & Johnson in 1982. Previously he was
founder and President of Aerotech Laboratories, a manufacturer of industrial
ultrasound electronics, which was acquired by Smith Kline & French in 1970. He
has served as a director of Geisinger Medical Center and president and
director of Lewistown Hospital. In 1988, he was awarded the Pioneer in
Ultrasound Award by the American Institute of Ultrasound in Medicine.
JOHN R. MILLER. Mr. Miller (age 57) has served as a Director of ATL since
July 16, 1993 and is a member of the Compensation Committee. He is currently a
senior advisor to Chanen, Painter & Co., Ltd., an investment bank with offices
in Seattle, Washington. Mr. Miller is also a Senior Fellow of the Discovery
Institute for Public Policy and Chairman of the Cascadia Project in Seattle.
From 1985 to 1992, Mr. Miller served as a U.S. Congressman for the First
District of Washington State. While a Member of Congress, he served on the
Budget Committee and the Foreign Affairs Committee, including the Subcommittee
on International Economic Policy and Trade, International Operations. Mr.
Miller was a member of Phi Beta Kappa and received his Bachelor of Arts degree
from Bucknell University and a Doctor of Laws degree and Master of Economics
degree from Yale University Law and Graduate Schools, respectively.
PHILLIP M. NUDELMAN, PH.D. Dr. Nudelman (age 60) has served as a Director of
ATL since October 28, 1994. He has served as Chief Executive Officer and
President of Group Health Cooperative of Puget Sound ("Group Health") since
February 1991. Dr. Nudelman joined Group Health in 1973 as Director of
Professional Services and has held positions of increasing responsibility
since then. He received his Bachelor of Science degree in Microbiology,
Zoology and Pharmacy from the University of Washington, and holds Master of
Business Administration and Doctor of Philosophy degrees in Health Systems
Management from Pacific Western University. Dr. Nudelman is a member of the
American Hospital Association House of Delegates, and chaired the Governing
Council for Health Care Systems. Dr. Nudelman is a member of the Boards of
Directors of Cell Therapeutics, Inc., Cytran, Inc. and SpaceLabs Medical, Inc.
He also serves on the boards of directors of American Healthcare Systems,
Inc., the Association of Washington Business, and the Foundation for Health
Care Quality.
HARRY WOOLF, PH.D. Dr. Woolf (age 72) has served as a Director and a member
of the Compensation Committee of ATL since January 2, 1987. He has also served
as Chairman of ATL's Scientific Advisory Board since May 1, 1987. In 1987, Dr.
Woolf completed an 11-year appointment as the director of The Institute for
Advanced Study, Princeton, New Jersey, and is currently a Professor Emeritus
at the Institute. Dr. Woolf received his Bachelor of Science and Master of
Arts degrees from the University of Chicago and his Doctor of Philosophy
degree from Cornell University. He has also received honorary doctorates from
Whitman College, American University, Johns Hopkins University and St.
Lawrence University. Dr. Woolf has been honored by election to the Academie
Internationale d'Histoire des Sciences, American Philosophical Society, Sigma
Xi, Phi Beta Kappa and American Academy of Arts and Sciences. He was a Trustee
of the Rockefeller Foundation (1984-1994) and is a Trustee of Reed College.
Dr. Woolf is a member of the boards of directors of Alex. Brown Mutual Funds
and SpaceLabs Medical, Inc. He is also a director of the Johns Hopkins Program
for International Education on Gynecology and Obstetrics, Inc., and Family
Health International.
During 1995, there were 4 meetings of the ATL Board. All incumbent Directors
were in attendance at all meetings.
3
<PAGE>
DIRECTOR COMPENSATION
Directors who are employees of ATL do not receive any fee for their services
as Directors. Directors who are not employees of ATL are paid an annual
retainer of $25,000 and receive an additional fee of $500 for attendance at
each meeting of the ATL Board plus $500 for attendance at each meeting of a
committee of the ATL Board. A nonemployee Director serving as a committee
chairman receives an additional $1,000 per annum.
As approved by the shareholders on May 5, 1993 and amended by shareholders
on May 10, 1995, Directors who are not employees of ATL are also eligible for
a grant of stock options under the Director Plan. Each nonemployee Director
automatically receives annually, on the first day of July, an option to
purchase 5,000 shares of ATL Common Stock, at an exercise price equal to the
fair market value on the date of grant. In 1995, Messrs. Cramer, Feigenbaum,
Miller, Nudelman and Woolf were recipients of grants under the Director Plan.
Dr. Feigenbaum has made arrangements for any proceeds realized from his ATL
stock options to be donated to charity. All nonemployee Directors currently
proposed to serve as Directors are eligible for grants in 1996. Subject to
shareholder approval of the proposed amendment to the Director Plan, each
nonemployee Director will receive an option to purchase 5,000 shares of ATL
Common Stock each year.
In 1995, Dr. Harvey Feigenbaum received $45,000 as a member of the
Scientific Advisory Board.
In 1995, Mr. Larson received $214,500 for consulting services to the
Company, and $40,000 for his services as a member of the Scientific Advisory
Board.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
In 1995, Dr. Harry Woolf received $50,000 in his capacity as Chairman of the
Scientific Advisory Board. Dr. Woolf is a member of the Compensation Committee
of the Board.
COMMITTEES OF THE ATL BOARD
ATL has established standing committees of the ATL Board, including Audit,
Compensation and Executive Committees. In addition, Directors serving on the
Scientific Advisory Board participate in and direct the setting of ATL's
technology strategy. The Board of Directors does not have a standing
nominating committee. Each of the committees is responsible to the full ATL
Board, and its activities are therefore subject to approval of the ATL Board.
The functions performed by these committees can be summarized as follows:
AUDIT COMMITTEE. The Audit Committee reviews the accounting principles,
internal accounting controls, audit plan and financial results of ATL in order
to safeguard ATL's assets and to provide for the reliability of its financial
records. The members of this Committee are Dr. Feigenbaum (Chairman), Mr.
Cramer and Dr. Nudelman. The Audit Committee met four times during 1995. All
members were in attendance at all meetings.
COMPENSATION COMMITTEE. The Compensation Committee establishes salaries,
incentives and other forms of compensation for directors, officers and other
executives of ATL and its subsidiaries. This Committee also administers ATL's
various incentive compensation and benefit plans and recommends the
establishment of policies relating to incentive compensation and benefit
plans. The members of this Committee are Mr. Cramer (Chairman), Mr. Miller and
Dr. Woolf. This Committee met four times during 1995. All members were in
attendance at all meetings.
EXECUTIVE COMMITTEE. The Executive Committee has authority, subject to
limitations prescribed by the ATL Board, to exercise, during the intervals
between meetings of the ATL Board, the powers of the full ATL Board, and is
also available, on a standby basis, for use in an emergency or when scheduling
makes it impractical to bring the full ATL Board together for a meeting. The
members of this Committee are Mr. Fill (Chairman), Dr. Feigenbaum, Mr. Cramer
and Mr. Larson. This Committee did not meet during 1995.
4
<PAGE>
Scientific Advisory Board. The Scientific Advisory Board meets with a group
of senior scientists of ATL known as the Senior Technical Staff ("STS") and
has the authority to control and direct ATL's technology strategy. Regular
meetings of the STS are held weekly, and members of the Scientific Advisory
Board attend these meetings as circumstances dictate. The members of the
Scientific Advisory Board are Dr. Woolf (Chairman), Dr. Feigenbaum and Mr.
Larson.
SECTION 16 REPORTING
Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act")
requires ATL's officers and directors and persons who own more than 10% of a
registered class of ATL's equity securities to file reports of ownership and
changes in ownership with the Securities and Exchange Commissions (the "SEC").
Officers, directors and greater than 10% shareholders are required by SEC
regulations to furnish ATL with copies of all Section 16(a) forms they file.
Based solely on its review of the copies of such forms received by it, or
written representations from certain reporting persons that no forms were
required for those persons, ATL believes that during calendar year 1995 all
filing requirements applicable to its officers, directors and greater than 10%
shareholders were in compliance, except for the following; Harvey N. Gillis,
Senior Vice President and Chief Financial Officer, was late in reporting the
conversion of 100 shares of Interspec, Inc. into 41 shares of ATL Common
Stock, pursuant to a merger between the companies, and Richard A. Totorica,
Corporate Controller, was late in reporting the grant of stock options in the
amount of 2,800 shares in 1995, which reporting was due on February 14, 1996.
All late disclosures have been filed by amendment.
5
<PAGE>
STOCK OWNERSHIP OF DIRECTORS AND EXECUTIVE OFFICERS
The following table sets forth information as of March 1, 1996 known by the
Company with respect to each shareholder to be the beneficial owner of more
than five percent of any class of voting securities of the Company, each
Director, each Named Executive Officers as described in the Summary
Compensation Table and all Directors and executive officers of the Company as
a group. Each of the named persons and members of the group has sole voting
and investment power with respect to the shares shown, except as stated below.
As of March 1, 1996 there were 13,857,270 shares of Common Stock issued and
outstanding.
BENEFICIAL OWNERSHIP OF SHARES
<TABLE>
<CAPTION>
AMOUNT AND
NATURE OF PERCENT
NAME AND ADDRESS OF BENEFICIAL OF
BENEFICIAL OWNER OWNERSHIP(1) CLASS
------------------- ------------ -------
<S> <C> <C>
5% OWNERS
ICM Asset Management,
Inc...................... 1,180,650(2) 8.5%
601 W. Main Avenue,
suite 917
Spokane, WA 99201
The State of Wisconsin
Investment Board......... 907,100(3) 6.5%
P.O. Box 7842
Madison, WI 53707
Wellington Management
Company.................. 731,950(4) 5.3%
75 State Street
Boston, MA 02109
Trimark Investment
Management Inc........... 659,100(5) 4.8%
One First Canadian Place
Suite 5600, P.O. Box 487
Toronto, Ontario M5X 1E5
DIRECTORS AND EXECUTIVE
OFFICERS
Dennis C. Fill........... 335,785(6) 2.4%
Harvey N. Gillis......... 57,968(6) *
Eugene A. Larson......... 49,400 *
Jacques Souquet.......... 26,963(6) *
Castor F. Diaz........... 26,108(6) *
Donald D. Blem........... 20,547(6) *
Kirby L. Cramer.......... 14,000 *
Harry Woolf.............. 10,000 *
Harvey Feigenbaum........ 4,463(7) *
John R. Miller........... 2,300 *
Phillip M. Nudelman...... 100 *
All Directors and
Executive Officers
as a Group (12 Persons). 571,489(1)(6) 4.1%
</TABLE>
- --------
*Under one percent.
(1) Includes Director and executive officer stock options exercisable within
60 days of March 1, 1996.
(2) Sole power to vote 652,760 shares and sole power to dispose of 1,180,650
shares, based upon publicly available information reported as of December
31, 1995.
(3) Sole power to vote and sole power to dispose of 907,100 shares, based upon
publicly available information reported as of December 31, 1995
(4) Shared power to vote 48,650 and shared power to dispose of 731,950 shares,
based upon publicly available information reported as of December 31,
1995, including 683,300 shares held through Wellington Management Company
are beneficially owned by Vanguard Specialized Porfolios, Inc.--Health
Care
6
<PAGE>
Portfolios ("Vanguard"), P.O. Box 2600 Valley Forge, PA 19482. Vanguard has
sole power to vote and sole power to dispose of 683,300 shares.
(5) Sole power to vote and sole power to dispose of 659,100 shares, based upon
publicly available information reported as of December 31, 1995.
(6) Includes shares held by the Trustee of ATL's Incentive Savings and Stock
Ownership Plan (the "ISSOP/401(k)") for each such executive officer and/or
Director who is a participant in the ISSOP/401(k). Does not include shares
purchased by the Trustee of the ISSOP/401(k) after December 31, 1995,
which shares have not yet been allocated by such trustee to each of the
beneficiaries.
(7) Includes 163 shares owned by Dr. Feigenbaum's wife. Dr. Feigenbaum
disclaims beneficial ownership as to all such shares.
COMPENSATION OF EXECUTIVE OFFICERS
The following table sets forth information concerning compensation for the
fiscal years 1995, 1994 and 1993 for services in all capacities to the Company
and its subsidiaries by persons who, at December 31, 1995 were the Chief
Executive Officer and the Company's four most highly compensated executive
officers of the Company, other than the Chief Executive Officer (collectively,
the "Named Executive Officers").
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
ANNUAL LONG TERM
COMPENSATION COMPENSATION AWARDS
---------------- -----------------------
NUMBER OF
RESTRICTED SECURITIES ALL OTHER
STOCK UNDERLYING COMPEN-
NAME AND PRINCIPAL SALARY BONUS(1) AWARDS(2)(3) OPTIONS SATION(4)
POSITION YEAR ($) ($) ($) (#) ($)
------------------ ---- ------- -------- ------------ ---------- ---------
<S> <C> <C> <C> <C> <C> <C>
Dennis C. Fill 1995 481,730 500,000 0 0 9,240
Chairman and Chief 1994 428,746 112,000 815,130 0 8,925
Executive Officer 1993 370,107 236,120 328,880 75,000 3,935
Harvey N. Gillis, 1995 233,800 145,000 0 0 9,000
Sr. Vice President
and Chief 1994 215,096 36,000 18,880 20,000 4,245
Financial Officer 1993 193,846 76,120 90,000 25,000 1,090
Castor F. Diaz 1995 251,014 100,000 78,075 40,000 52,425(5)
Sr. Vice President, 1994 187,771 25,000 12,800 8,000 77,476(6)
Worldwide Sales and 1993 162,451 52,200 12,800 17,000 52,432(7)
Marketing
Donald D. Blem 1995 192,000 130,000 0 21,000 6,030
Sr. Vice President, 1994 175,739 25,000 0 7,000 0
Operations 1993 155,076 56,240 13,760 12,000 2,215
Jacques Souquet 1995 185,846 130,000 0 17,000 9,240
Sr. Vice President,
Product 1994 165,577 25,000 0 9,000 7,500
Generation 1993 142,500 40,080 9,920 17,000 7,125
</TABLE>
- --------
(1) Includes bonus awards earned during the fiscal year covered under the
Company's Management Incentive Compensation Plan (the "MIC Plan"). See
"Compensation Committee Report on Executive Compensation."
(2) Restricted stock awards generally have a vesting period of four years with
25% of the award amount vesting each year on the anniversary date of the
award. The rights of a restricted shareholder include the right to receive
any dividends or other distributions made or paid with respect to such
shares. The amounts reported in this table represent the market value of
the shares at the date of grant based upon the closing price of the Common
Stock reported on the Nasdaq National Market on such date. At December 31,
1995 Messrs. Fill, Gillis, Diaz, Blem and Souquet held 68,090, 6,840,
7,150, 2,680 and 1,810 shares of restricted stock,
7
<PAGE>
respectively, having a market value of $1,668,205, $167,580, $103,675,
$65,660 and $44,345, respectively, based upon the closing price of the
Common Stock reported on the Nasdaq National Market on December 29, 1995.
See description of the 1992 Plan in PROPOSAL 2.
(3) Includes bonus awards of restricted stock on February 18, 1994, which
represent 20% of the cash value of an award under the MIC Plan for the
fiscal year 1993. Under these MIC Plan awards, Messrs. Fill, Gillis, Diaz,
Blem and Souquet received 3,680, 1,180, 800, 860, and 620 shares,
respectively, having a market value of $58,880, $18,880, $12,800, $13,760
and $9,920 respectively. These restricted shares granted had a two-year
vesting period with 50% of the award amount vesting each year on the
anniversary date of the award.
(4) Includes employer-matching contributions made to the ISSOP/401(k) Plan.
(5) Includes $18,084 in expatriate benefits, $7,775 and $17,326 in automobile
and housing allowance, respectively. In 1995 Mr. Diaz returned from
overseas assignment in Germany.
(6) Includes $32,563 in expatriate benefits and $22,323 in housing allowance.
(7) Includes $31,914 in expatriate benefits and $13,869 in automobile
allowance.
OPTION/SAR GRANTS
The following table sets forth certain information regarding options granted
during the fiscal year ended December 31, 1995 to the Named Executive Officers.
No SARs were granted in fiscal 1995.
OPTION/SAR GRANTS IN FISCAL 1995
<TABLE>
<CAPTION>
POTENTIAL
REALIZABLE
VALUE AT
ASSUMED ANNUAL
RATES OF STOCK
PRICE
APPRECIATION
FOR OPTION
INDIVIDUAL GRANTS TERM(2)(3)
- --------------------------------------------------------------- ---------------
PERCENT OF
NUMBER OF TOTAL
SECURITIES OPTIONS
UNDERLYING GRANTED TO
OPTIONS EMPLOYEES
GRANTED IN FISCAL EXERCISE EXPIRATION
NAME (#)(1) YEAR PRICE($/SH) DATE 5% ($) 10% ($)
- ---- ---------- ---------- ----------- ---------- ------- -------
<S> <C> <C> <C> <C> <C> <C>
Dennis C. Fill.... 0 0 0 0 0 0
Harvey N. Gillis.. 0 0 0 0 0 0
Castor F. Diaz.... 25,000 6.4% 15.63 2/17/05 245,662 622,556
15,000 3.9 16.75 7/28/05 159,010 400,428
Donald D. Blem.... 10,000 2.6 15.63 2/17/05 98,265 249,022
11,000 2.8 16.75 7/28/05 115,874 293,647
Jacques Souquet... 10,000 2.6 15.63 2/17/05 98,265 249,022
7,000 1.8 16.75 7/28/05 73,738 186,866
</TABLE>
- --------
(1) Options granted under the 1992 Plan are granted at the fair market value on
the date of grant and generally vest over four years with 25% of each grant
exercisable on the successive anniversary dates of grant. Certain changes
in control of ATL including certain changes in Board membership, Common
Stock ownership by a single entity, merger or liquidation, can trigger
accelerated vesting of stock options and rights to related payments. See
description of the 1992 Plan in PROPOSAL 2.
(2) The dollar amounts under these columns are the result of calculations at
assumed rates of 5% and 10% and are not intended to forecast future
appreciation. No value will be realized if the stock price does not exceed
the exercise price of the options.
8
<PAGE>
(3) The appreciation realized by all ATL shareholders on all 13,609,731 shares
of ATL Common Stock outstanding on December 31, 1995, starting from a base
value of $16.71 per share, which represents the average grant price for
stock options granted under the ATL Option Plan during 1995, would be
$143,046,303 and $362,505,256 at assumed annual rates of stock price
appreciation of 5% and 10%, respectively.
OPTION EXERCISES AND YEAR-END VALUES
The following table sets forth certain information as of December 31, 1995,
regarding options held by the Named Executive Officers. None of such
individuals exercised any options during the fiscal year ended December 31,
1995.
AGGREGATED FISCAL 1995 YEAR-END OPTION VALUES
<TABLE>
<CAPTION>
NUMBER OF SECURITIES VALUE OF UNEXERCISED
UNDERLYING UNEXERCISED IN-THE-MONEY OPTIONS AT
OPTIONS AT FY-END (#) FY-END ($)(1)
------------------------- -------------------------
NAME EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C>
Dennis C. Fill............. 193,750 56,250 1,865,991 414,843
Harvey N. Gillis........... 36,250 33,750 304,843 283,281
Castor F. Diaz............. 17,250 56,750 141,363 489,906
Donald D. Blem............. 15,250 34,750 125,125 296,125
Jacques Souquet............ 16,000 34,000 131,468 291,906
</TABLE>
- --------
(1) This amount is the aggregate number of the outstanding options multiplied
by the difference between the closing price of the ATL Common Stock as
reported on the Nasdaq National Market on December 29, 1995, minus the
exercise price of such options.
LONG-TERM INCENTIVE AWARDS
The following table sets forth certain information regarding the Company's
Long-Term Incentive Plan awards granted in fiscal year 1995 to the Named
Executive Officers.
LONG-TERM INCENTIVE PLAN--AWARDS IN LAST FISCAL YEAR
<TABLE>
<CAPTION>
PERFORMANCE ESTIMATED FUTURE PAYOUTS
OR OTHER UNDER NON-STOCK PRICE-BASED
PERIOD PLANS(1)(2)(3)
NUMBER OF UNTIL ---------------------------
SHARES, UNITS OR MATURATION THRESHOLD TARGET MAXIMUM
NAME OTHER RIGHTS (#) OR PAYOUT ($ OR #) ($ OR #) ($ OR #)
---- ---------------- ----------- --------- -------- --------
<S> <C> <C> <C> <C> <C>
Dennis C. Fill.......... -- 1995-1997 0 $252,908 $505,817
Harvey N. Gillis........ -- 1995-1997 0 $ 98,196 $196,392
Castor F. Diaz.......... -- 1995-1997 0 $105,426 $210,852
20,000 units (4) 1995-1997
Donald D. Blem.......... -- 1995-1997 0 $ 80,640 $161,280
Jacques Souquet......... -- 1995-1997 0 $ 78,055 $156,111
</TABLE>
- --------
(1) Similar awards granted in 1993 did not have value at maturity on December
31, 1995. It is unlikely that the 1994 awards will have value at maturity
on December 31, 1996.
(2) No payouts will be made prior to the end of the maturation period on
December 31, 1997.
(3) Awards, which are payable in cash, are determined as a percentage (0% to
105%) of a recipient's base salary. In 1995, the base salaries of Messrs.
Fill, Gillis, Diaz, Blem and Souquet were $481,730, $233,800, $251,014,
$192,000 and $185,846, respectively. See "Compensation Committee Report on
Executive Compensation."
(4) Mr. Diaz earned performance unit incentives during 1995 which will mature
on January 1, 1998 at which time each unit will have a cash value equal to
the market price of one share of ATL Common Stock on that date. See
"Compensation Committee Report on Executive Compensation."
9
<PAGE>
COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION
Compensation Policies. The Compensation Committee has developed and directs
a comprehensive program of compensation policies that aligns the compensation
of all employees, including senior management, in accordance with goals and
objectives that are consistent with ATL's business strategies. These business
strategies are designed to enhance business financial performance and customer
satisfaction and are thereby aligned with the overall corporate objective of
enhancing shareholder value. ATL's compensation policies are designed to
attract and retain key employees, including executive officers, in competition
with other high-technology companies that endeavor to attract such employees
The Compensation Committee is advised by an outside compensation consultant
on all aspects of compensation, including base salaries, bonus awards and
incentives, including restricted stock, stock options and long-term incentive
awards. Incentive awards payable to those engaged in sales activities are
based upon performance as measured by objective standards, and are set by the
Company's sales organization.
Compensation Programs. The Compensation Committee and ATL's shareholders
have adopted incentive programs that reach all areas of ATL. Under the 1992
Plan (see PROPOSAL 2) and the Management Incentive Compensation Plan (the "MIC
Plan"), awards may be granted to any officer or manager of ATL in the form of
stock options, stock appreciation rights ("SARs"), restricted stock, grants of
stock, performance units, and cash bonuses. Under the Nonofficer Employee
Stock Option Plan (the "NOE Plan"), stock option awards may be made to any
employee who is not an officer of the Company. Under the Long Term Incentive
Plan, designated employees of ATL may earn incentive awards over a period of
years which are premised on objective measures of company performance. The
Compensation Committee has adopted a Profit Sharing Plan in which all
employees not participating in the Long Term Incentive Plan are eligible for
cash bonuses based upon their base salaries and paid from an award pool
established by objective criteria of return on sales. All awards to executive
officers under the above plans must be reviewed and approved by the
Compensation Committee. In addition, all employees are eligible to participate
in the Incentive Savings and Stock Ownership Plan following the initial year
of employment with ATL.
Compensation of Executive Officers. The total compensation program for
executive officers in 1995, including the Chief Executive Officer, was
balanced among base salary, an annual bonus, long term incentives, restricted
stock and stock option grants vesting over a four-year period. The
Compensation Committee considered the reports and advice of outside
consultants in the area of executive compensation in determining each element
of compensation and each individual's total incentive compensation.
Salaries. The Compensation Committee utilizes an executive salary structure
recommended to the Company by an outside compensation consulting firm and
based upon the 1993 Radford Associates Management Total Compensation Report.
Salary ranges were based upon the 50th and 75th percentile data for comparable
positions in high technology companies comparable to ATL. In 1995 the
Compensation Committee adjusted the salaries of nine executive officers in
line with this structure.
Bonuses. Traditionally, a portion of ATL's total compensation is paid in the
form of bonuses. Annual bonuses for all managers, including executive
officers, may be awarded by the Compensation Committee from an award pool
established under the MIC Plan. The size of the award pool is based on ATL's
corporate performance measured by quantified factors of revenue and earnings,
and by strategic factors aligned with ATL's business plan for the year.
Individual bonus awards were made by the Compensation Committee in
consideration of a recipient's managerial level and the recipient's individual
performance as measured by the corporate objectives set for the recipient, and
the effectiveness of the recipient in achieving those objectives.
Bonuses awarded to executive officers for 1995 were determined in accordance
with the criteria of the MIC Plan award pool described above. In 1995 the size
of the award pool was determined by the measure of achievement of ten Company
priorities which the Board had established for 1995, and five additional
developments which were not foreseen at the beginning of the year.
10
<PAGE>
Equity Awards. From time to time the Compensation Committee grants awards of
restricted stock and stock options under the 1992 Plan and the NOE Plan. The
objectives of these grants are to recognize, reward and retain individuals in
key positions who have exhibited high performance and have high potential for
advancement with ATL. Every recommendation for an award is individually
brought before the Compensation Committee by management. In 1995 the
Compensation Committee focused its attention on the award of stock options to
key employees below the executive officer level and granted stock option
awards to 88 non-officer employees of the Company. The Compensation Committee
also allocated a number of restricted stock and stock option incentives for
award to employees of the Company's Interspec division who were relocating to
other units of the Company. This program resulted in the award of stock
options and restricted shares to 23 relocating Interspec employees.
In 1995 there were no equity awards to executive officers as a group. During
the year the Compensation Committee granted selected stock option awards to
bring uniformity to the level of incentives which may be earned by all senior
vice presidents. Other selected equity awards made in 1995 reflected the
promotion or individual achievements of specific individuals. All equity
awards vest in equal annual installments over a four-year period beginning one
year after the grant date. In February, 1995 Mr. Diaz was promoted to the
position of Senior Vice President of Sales and Marketing, and in recognition
thereof was awarded restricted stock, stock options, and a grant of
performance units. The performance units vest after a period of three years,
at which time they will have a value based upon the value of ATL stock at that
time and the achievement of certain key Company objectives.
Other than the award to Mr. Diaz, there are at present no awards or
contracts outstanding for SARs or performance unit awards under the 1992 Plan.
In 1995, as in previous years, the only stock grants awarded by the
Compensation Committee were in recognition of achievements by the Company's
sales representatives and senior scientists.
Long-Term Incentive Awards. The Compensation Committee set the terms of
performance incentives for certain executive officers under the Long Term
Incentive Plan in 1995. These incentives are to be earned over a three-year
term as determined by predetermined objective criteria of corporate
performance and will not mature until the end of 1997, at which time they may
or may not have value. The long-term incentive for each recipient is premised
on a fraction of the recipient's base salary and is limited to a maximum
percentage of salary. Similar incentives from 1993 had no value at maturity at
the end of 1995 and incentives awarded in 1994 are not expected to have value
when they mature at the end of the three year award cycle.
Compensation of the Chief Executive Officer. Mr. Fill received no restricted
stock or stock option awards in 1995. In May, 1995 the Compensation Committee
set Mr. Fill's salary at $500,000 in consideration of the improvement of the
Company's profitability, the progress made in the introduction of new
products, and the consolidation of the Company's operations. Mr. Fill received
a 1995 bonus of $500,000 in consideration of the significant improvement in
the Company's earnings, the strengthened balance sheet of the Company, the
Company's record revenues for the year, the alliance reached with Hitachi
Medical Corporation, the Food and Drug Administration advisory panel
recommendation of the Company's new clinical indication for breast ultrasound,
and the completion of the consolidation of the Company's Ambler, Pennsylvania
operations.
Compensation Committee
Mr. Kirby L. Cramer, Chairman
Dr. Harry Woolf
Mr. John R. Miller
11
<PAGE>
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN
The graph set forth below represents the five-year cumulative total return
on shares of ATL Common Stock, the S&P 500 Stock Index, and a Peer Group
Industry Index resulting from an initial assumed investment of $100 in each.
The Peer Group Industry Index is a representative grouping of 85 companies
from SIC Code 3845-Electromedical & Electrotherapeutic Apparatus*-which had
five years of reportable stock performance and includes the reinvestment of
both cash and stock dividends. The graph has been prepared by an outside
consulting firm to ATL. The ATL cumulative return is computed as required by
the rules of the SEC to comprise the cumulative total return on Westmark
common stock (including both SpaceLabs Medical, Inc. and ATL subsidiaries)
prior to June 29, 1992, and to thereafter comprise the cumulative return of
shares of ATL Common Stock with a dividend reinvestment of the 1992
Distribution. By reason of this computation, the separate value of shares of
ATL Common Stock on a stand-alone basis cannot be distinguished in the graph.
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN AMONG
ADVANCED TECHNOLOGY LABORATORIES, INC., S&P 500 STOCK INDEX AND PEER GROUP
INDUSTRY INDEX*
<TABLE>
<CAPTION>
[GRAPH APPEARS HERE]
Measurement Period ADVANCED TECHNOLOGY S&P
(Fiscal Year Covered) LABORATORIES, INC. 500 INDEX PEER GROUP
- ------------------- ------------------- --------- ----------
<S> <C> <C> <C>
Measurement Pt-
12/31/90 $100 $100 $100
FYE 12/31/91 $216.33 $130.48 $191.66
FYE 12/31/92 $141.44 $140.46 $171.51
FYE 12/31/93 $135.38 $154.62 $148.76
FYE 12/31/94 $149.53 $156.66 $164.71
FYE 12/31/95 $198.02 $215.54 $289.57
</TABLE>
*A list of the component companies in this Industry Index will be provided,
at no charge to shareholders, upon request.
12
<PAGE>
Retirement Plan
The following tabulation shows the estimated annual benefits of an employee,
assuming annual benefits to an employee for retirement on January 1, 1996 at
age 65 after selected periods of service under the ATL Retirement Plan (the
"Retirement Plan"), and including amounts to be paid pursuant to the ATL
Supplemental Benefit Plan (the "Supplemental Plan"), if applicable.
<TABLE>
<CAPTION>
ANNUAL RETIREMENT BENEFIT FOR CREDITABLE SERVICE
AVERAGE ------------------------------------------------
ANNUAL 15 20 25 30
ARNINGSE 5 YEARS 10 YEARS YEARS YEARS YEARS YEARS
- -------- ------- -------- ------- ------- ------- -------
<S> <C> <C> <C> <C> <C> <C>
$100,000...................... 5,000 10,000 15,000 20,000 25,000 30,000
200,000...................... 10,000 20,000 30,000 40,000 50,000 60,000
300,000...................... 15,000 30,000 45,000 60,000 75,000 90,000
400,000...................... 20,000 40,000 60,000 80,000 100,000 120,000
500,000...................... 25,000 50,000 75,000 100,000 125,000 150,000
600,000...................... 30,000 60,000 90,000 120,000 150,000 180,000
700,000...................... 35,000 70,000 105,000 140,000 175,000 210,000
800,000...................... 40,000 80,000 120,000 160,000 200,000 240,000
</TABLE>
The Retirement Plan was amended effective January 1, 1995, and provides that
upon retirement a participant will receive a monthly benefit equal to the
greater of (i) 1.0% of the participant's final average monthly earnings
(earnings as defined in the Retirement Plan) multiplied by the participant's
years of credited service earned before December 31, 1993 plus 1% of
participant's final average monthly earnings taking into account all periods
multiplied by credited service earned after December 31, 1993, or (ii) 1.0% of
participant's final average monthly earnings multiplied by the participant's
years of credited service, with the Company and its subsidiaries. The
executive officers participate in the same manner as other eligible employees
in the Retirement Plan, which pays to vested employees the estimated maximum
annual retirement benefits at age 65. A participant is vested upon the
completion of five years of service. Benefits are also provided to a
participant's surviving spouse in the event of the participant's death prior
to retirement.
Amounts shown in the above table will be reduced by the actuarial equivalent
value of amounts distributed from the Discretionary Contribution Plan, which
was terminated in 1989, but in no event will they be less than zero.
Retirement benefits are not offset for Social Security benefits. The Employee
Retirement Income Security Act of 1974, the Tax Equity and Fiscal
Responsibility Act of 1982 and the Tax Reform Act of 1986 (the "Code")
generally limit the amount of annual pension which may be paid from a federal
income tax qualified plan to varying amounts (currently $120,000) and the
annual earnings which may be taken into account for purposes of calculation of
benefits under a federal income tax qualified plan (currently $150,000). The
actual amounts paid under the Retirement Plan will be limited to comply with
such legislation.
As of December 31, 1995 the number of years of credited service under the
Retirement Plan for Messrs. Fill, Gillis, Diaz, Souquet and Blem were
approximately 9, 3, 8, 6 and 7, respectively. The 1995 earnings for purposes
of calculation of benefits under this Retirement Plan for Messrs. Fill,
Gillis, Diaz, Souquet and Blem are $593,730, $269,800, $178,261, $210,846 and
$217,000, respectively. Subject to the limitations imposed by the Code, as
stated above, 1995 annual earnings in excess of $150,000 shall be disregarded.
The Supplemental Plan is an unfunded plan, not qualified for Federal income
tax purposes, which covers any employee whose benefit under the Retirement
Plan is limited by certain provisions of the Code. Based on earnings as
defined in the Retirement Plan, Messrs. Fill, Gillis, Diaz, Souquet, and Blem
would be eligible for benefits under the Supplemental Plan.
EMPLOYMENT AGREEMENTS
Messrs. Fill and Gillis have each entered into a Change in Control
Employment Agreement with ATL that provides for continued employment terms
equivalent to those immediately prior to a Change of Control (as
13
<PAGE>
defined in the 1992 Plan) for the three years following a Change of Control. A
lump-sum payment equal to three years of salary and bonus is immediately
triggered if, following a Change of Control, employment is terminated by (i)
the employee for "good cause" or during the 30-day window period one year
after the Change of Control or (ii) the employer "without cause." A Change of
Control, with or without termination of employment, also triggers an
acceleration of vesting of restricted stock and stock options and payment of
the "spread" between the exercise price of options and the fair market value
of the underlying ATL Common Stock. In 1994 the Compensation Committee amended
Mr. Fill's Change in Control Employment Agreement to continue his services
with the Company beyond age 65. Upon his retirement an award of 50,000 shares
of restricted stock to Mr. Fill will vest, his life insurance coverage will
continue, and he will consult for the Company for an additional five years.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
See also "Director Compensation" and "Compensation Committee Interlocks And
Insider Participation."
PROPOSAL 2: AMENDMENT OF THE 1992 OPTION, STOCK APPRECIATION RIGHT,
RESTRICTED STOCK, STOCK GRANT AND PERFORMANCE UNIT PLAN
General. The Board of Directors has adopted the Amended 1992 Option, Stock
Appreciation Right, Restricted Stock, Stock Grant and Performance Unit Plan
(the "1992 Plan"), which was approved by the shareholders of the Company on
May 18, 1992 and amended in 1994. Under the 1992 Plan, the Company is
presently authorized to issue 2,150,000 shares of Common Stock pursuant to
awards of incentive stock options, nonqualified stock options, stock
appreciation rights, restricted stock, stock grants and performance units, of
which up to an aggregate of 550,000 shares may be issued as restricted stock
awards and stock grants. Of this authorization, only 21,514 shares were
available as of February 28, 1996 for future awards under the 1992 Plan.
Proposed Amendment. The Board of Directors approved a proposed amendment to
the 1992 Plan on February 22, 1996. The Shareholders will be asked at the
Annual Meeting to consider and approve this amendment to the 1992 Plan to
reserve an additional 550,000 shares of Common Stock for issuance pursuant to
awards granted under the 1992 Plan, of which not more than 150,000 may be
issued as restricted stock or stock grant awards. The Board of Directors
believes that the proposed amendment to the 1992 Plan is necessary to attract
and retain the services of experienced and knowledgeable employees in a
competitive high technology industry where the Company's competitors are able
to attract and retain highly qualified employees as a result, in part, of
their various stock option and equity participation plans. In making this
recommendation the Board is mindful of the fact that a large, multinational
corporation has recently located its ultrasound division less than 12 miles
from ATL's headquarters. It is important for the Company to be able to provide
continued incentives to its key employees to retain those who are a critical
resource of the Company and to be able to attract new talent for new markets
and products.
Description of the 1992 Plan. There are reserved for issuance upon the
exercise of options, for the issuance of restricted stock and stock grant
awards and for issuance upon the payment of performance units and stock
appreciation rights under the 1992 Plan 2,150,000 shares of Common Stock, of
which no more than 550,000 shares may be issued as restricted stock awards and
stock grants under the Plan. The proposed amendment to the 1992 Plan would
increase the number of shares available under the Amended and Restated Plan to
2,700,000, of which the number of shares available for restricted stock and
stock grant awards will be 700,000 shares.
Eligibility to Receive Awards. Employees, consultants and independent
contractors of ATL selected by the Company's Compensation Committee are
eligible to receive awards of options, stock appreciation rights, restricted
stock grants and/or performance units under the 1992 Plan. In accordance with
a Plan amendment approved by the Shareholders in 1994 to comply with Section
162(m) of the Code the maximum number of shares of Common Stock to which an
option or options or stock appreciation rights may be granted to any eligible
employee in any one fiscal year of the Company shall not exceed ten percent of
the aggregate number of shares of Common Stock authorized for issuance under
the plan (the "Maximum Annual Employee Grant").
14
<PAGE>
Terms and Conditions of Stock Option Grants. The Compensation Committee is
authorized under the 1992 Plan, in its discretion, to issue options under the
1992 Plan as "Incentive Stock Options" (as defined in Section 422 of the Code
or as "Nonqualified Stock Options" (defined in the 1992 Plan as being all
other options granted thereunder). The option price for each option granted
under the 1992 Plan will be not less than 100% of the fair market value of the
Common Stock on the date of grant, except that, with respect to any
Nonqualified Stock Option, the option price may equal the average daily fair
market value of the ATL Common Stock calculated over any continuous period of
trading days beginning and ending no more than 30 business days before or
after the granting date of such option. For purposes of the 1992 Plan and the
Director Plan described in PROPOSAL 3, "fair market value" means the average
of the high and low sales prices of the Common Stock for the period in
question as quoted on the Nasdaq National Market.
Upon exercise the option price is to be paid in full in cash or, to the
extent permitted by the Compensation Committee, in Common Stock owned by the
optionee for at least three months and having a market value on the date of
exercise equal to the aggregate option price, or in a combination of cash and
stock. The option price may also be paid by delivery of a properly executed
exercise notice, together with irrevocable instructions to a broker designated
by the Company to promptly deliver the exercise price to the Company. The
option price under each option will remain constant during the life of such
option, regardless of changes in the market value of the Common Stock. No cash
consideration will be paid to the Company by optionees for the granting of any
option. The optionee must pay to the Company applicable withholding taxes upon
exercise of the option as a condition to receiving the share certificates. The
withholding tax may be paid in cash or by the withholding or delivery of
Common Stock.
Each option will have a term of not more than 10 years from the date of
grant, and may be exercisable in installments as prescribed by the
Compensation Committee in the option grant, but no option can be exercisable
prior to the first anniversary of the date of grant except in the case of the
death of an optionee during employment or except as the Compensation Committee
otherwise determines. It is the present intention of the Compensation
Committee that both Nonqualified Stock Options and Incentive Stock Options
granted to employees under the 1992 Plan will become exercisable in annual
installments of 25% of the number of shares initially granted, commencing on
the first anniversary of the grant date, such installments to be cumulative,
and will not be exercisable prior thereto, except as described below.
If the employment of an optionee is terminated other than by reason of
death, normal or early retirement or disability, the optionee may exercise the
option at any time within one year after such termination (but not after the
expiration date of the option), to the extent of the number of shares
purchasable at the date of termination of employment.
In the event of the termination of the employment of an optionee because of
normal retirement or disability, the optionee may exercise such option at any
time prior to expiration of the option, to the extent of the remaining shares
covered by such option, whether or not such shares had become purchasable by
the optionee at the date of termination of employment. In the event of the
termination of the employment of an optionee because of early retirement, the
optionee may exercise such option at any time prior to expiration of the
option, to the extent of the remaining shares covered by such option, at such
time or times as such option becomes purchasable by the optionee in accordance
with its terms. In the event of the death of an optionee while the optionee is
employed by the Company or any of its subsidiaries or while such option is
otherwise outstanding, the option may be exercised by an optionee's
beneficiary or legal representative at any time within a period of one year
after the optionee's death, but not after the expiration of the option, to the
extent of the remaining shares covered by his or her option, whether or not
such shares had become purchasable by the optionee at the date of the
optionee's death. In the event of the death of an optionee during the one-year
period following the termination of the optionee's employment or following
termination of employment by reason of normal or early retirement or
disability, such option (unless such termination is for cause) may be
exercised by the optionee's beneficiary or legal representative, but only to
the extent of the number of shares purchasable by the optionee pursuant to the
provisions of his or her option at the date of termination of the optionee's
employment.
15
<PAGE>
Notwithstanding the foregoing provisions, but subject to the provisions of
the next paragraph, the Compensation Committee may determine, in its sole
discretion, in the case of any termination of employment that (i) the optionee
may exercise such option to the extent of the remaining shares covered thereby
whether or not such shares had become purchasable by the optionee at the date
of termination of his or her employment and (ii) such option may be exercised
at any time prior to the expiration of the original term of the option.
In the event that an optionee does not remain in the employ of the Company
or of one of its subsidiaries and the termination of the optionee's service is
for cause, the option will automatically terminate on the date of first
notification to the optionee of such termination unless the ATL Compensation
Committee otherwise determines.
The 1992 Plan also provides that, if the option grant so states, upon
notification of an intention to exercise a Nonqualified Stock Option, either
in whole or in part, the Compensation Committee may require the optionee to
surrender the option for cancellation, in lieu of exercising it, and receive
in exchange for such surrender a payment in cash and/or shares equal to the
difference between the option price of the shares covered by the option
surrendered for cancellation and the fair market value of such shares on the
date on which the optionee's notice of exercise is received by the Company.
Stock Appreciation Rights. Under the 1992 Plan the Compensation Committee is
authorized to grant stock appreciation rights ("SARs") to eligible employees,
consultants and independent contractors of the Company. An SAR is an incentive
award that permits the holder to receive (per share covered thereby) an amount
equal to the amount by which the fair market value of a share of ATL Common
Stock on the date of exercise exceeds the fair market value of such share on
the date the SAR was granted (the "base price").
The Compensation Committee may grant an SAR separately or in tandem with a
related option and may grant both "general" and "limited" SARS. A general SAR
granted in tandem with a related option will generally have the same terms and
Provisions as the related option with respect to exercisability, and the base
price of such an SAR will generally be equal to the option price under the
related option. Upon the exercise of a tandem SAR the related option will be
deemed to be exercised for all purposes of the 1992 Plan and vice versa.
A general SAR granted separately and not in tandem with any option will have
such terms as the Compensation Committee may determine, subject to the
provisions of the 1992 Plan. Under the 1992 Plan the base price of a stand-
alone SAR may not be less than the fair market value of the ATL Common Stock
determined as in the case of a Nonqualified Stock Option; the term of a stand-
alone SAR may not be greater than 10 years from the date it was granted.
A limited SAR may be exercised only during the 90 days immediately following
a Change of Control (as defined below). For the purpose of determining the
amount payable upon exercise of a limited SAR, the fair market value of a
share of Common Stock will be equal to the higher of (x) the highest fair
market value of the Common Stock during the 90-day period ending on the date
the limited SAR is exercised, determined as in the case of an option, or (y)
whichever of the following is applicable:
(i) the highest per share price paid in any tender or exchange offer
which is in effect at any time during the 90 days preceding the exercise of
the limited right;
(ii) the fixed or formula price for the acquisition of shares of Common
Stock in a merger or similar agreement approved by the stockholders or
Board of Directors, if such price is determinable on the date of exercise;
and
(iii) the highest price per share paid to any stockholder of the Company
in a transaction or group of transactions giving rise to the exercisability
of the limited right.
General SARs granted in tandem with a related option are payable in cash,
Common Stock or any combination thereof as determined in the sole discretion
of the Compensation Committee. Limited SARs are payable only in cash. General
stand-alone SARs are also payable only in cash, unless the Compensation
Committee provides otherwise at the time of grant.
16
<PAGE>
Unless otherwise provided by the Compensation Committee at the time of
grant, the provisions of the 1992 Plan relating to the termination of
employment of a holder of a stock option will apply equally, to the extent
applicable, to the holder of an SAR.
No SARs have been granted under the 1992 Plan.
Restricted Stock Awards. The Compensation Committee is authorized under the
1992 Plan to issue shares of Common Stock to eligible employees, consultants
and independent contractors of the Company, such shares to be restricted as
hereinafter described. The consideration received for such shares by the
Company is the payment in cash of an amount equal to the par value thereof and
past services of the participant. The recipient of restricted stock will be
recorded as a stockholder of ATL and will have, subject to the restrictions
described below, all the rights of a stockholder with respect to such shares
and will receive all dividends or other distributions made or paid with
respect to such shares; provided that the shares themselves and any new,
additional or different shares or securities which the recipient may be
entitled to receive with respect to such shares by virtue of a stock split or
stock dividend or any other change in the corporate or capital structure of
the Company will be subject to the restrictions described below.
During a period of years following the date of grant, as determined by the
Compensation Committee, which will in no event be less than one year (the
"Restricted Period"), the restricted stock may not be sold, assigned,
transferred, pledged, hypothecated or otherwise encumbered or disposed of by
the recipient, except in the event of death or the transfer of the restricted
stock to ATL upon termination of the holder's employment. In the event of the
normal retirement or death of the recipient during the Restricted Period, the
restrictions on the shares will immediately lapse. In the event of the early
retirement of the recipient during the Restricted Period, the restrictions on
the shares will continue until they lapse in accordance with the terms of the
grant. If the employment of the recipient by the Company terminates during the
Restricted Period for any reason other than the retirement or death of the
employee, the shares of restricted stock held by the employee will be
forfeited to the Company and the employee must immediately transfer and return
the certificates for the restricted stock to the Company.
Stock Grant Awards. The 1992 Plan authorizes the Compensation Committee to
issue shares of Common Stock to nonofficer employees of the Company. The
consideration received for such shares by ATL is the payment in cash of an
amount equal to the par value thereof and past services. Each recipient of a
stock grant may receive a cash award at the time of grant in an amount
sufficient to offset the recipient's estimated tax liabilities arising from
the grant.
Performance Unit Awards. Performance units awarded under the 1992 Plan will
have a base value, expressed in dollars, determined by the Compensation
Committee on the day on which the award is granted which generally will be the
fair market value of the Common Stock on such day. This value is the "unit
base value". The actual amount paid to the employee, consultant or independent
contractor, as the case may be, by the Company when the award matures at the
end of the award cycle will depend on the achievement of cumulative
performance measures. These measures will be determined by the Compensation
Committee at the time the award is made and may include, but are not limited
to, cumulative targets with respect to earnings per share or pretax profits,
return on shareholders' equity, asset management, cash flow or return on
capital employed of the Company and/or one of its subsidiaries, divisions or
departments. The Compensation Committee will also determine the length of the
award cycle (which may not be less than three years), a payment schedule and
whether the payment will be made in cash, Common Stock or a combination of
cash and Common Stock. The payment schedule will provide a range of
percentages of the unit base value which will be payable to the participant in
the event that cumulative targets, of varying amounts, are achieved.
In instances where performance measures are not achieved, no award will be
payable. The Compensation Committee has discretion under the 1992 Plan to
apply performance measures on an absolute basis or relative to industry
indices and conclusively determine whether the measures have been achieved, as
well as to revise the payment schedules and performance measure formerly
determined by it if, in its judgment, significant economic or other changes
have occurred which were not foreseeable by the Committee when it set the
initial measures.
17
<PAGE>
A performance unit award will terminate if the participant does not remain
in the employ of the Company during the award cycle, except as the
Compensation Committee otherwise determines, and except in the case of death,
normal or early retirement or disability occurring after the first anniversary
of the date of grant of the award, in which event, if the performance measure
is met, a pro rata portion of the award will be paid based on the elapsed time
of the award cycle prior to death, retirement or disability.
No payment of a performance unit award will be made prior to the end of an
award cycle, except as the Compensation Committee otherwise determines and
except in the case of death, in which event the participant's beneficiary or
legal representative may elect, subject to the approval of the Compensation
Committee, to have the participant's pro rata portion of the award paid at the
end of the year in which death occurred.
Only one performance unit award has been made under the 1992 Plan. See
"Compensation Committee Report on Executive Compensation."
Transferability. The recipient's rights to the options, SARS, restricted
stock and performance units may not be assigned or transferred except by will
or the applicable laws of descent or distribution or to a designated
beneficiary.
Capital Adjustments. In the event of any changes in the outstanding stock of
the Company by reason of stock dividends, stock splits, recapitalizations,
mergers, consolidations, combinations or exchanges of shares, splitups, split-
offs, spin-offs, liquidations or other similar changes in capitalization, or
any distribution to stockholders other than cash dividends, the Compensation
Committee shall make such adjustments in the Maximum Annual Employee Grant, if
any, in light of the change or distribution as the Compensation Committee, in
its sole discretion, may make any adjustments it determines to be appropriate
in the outstanding options, stock appreciation rights, restricted shares or
performance units granted under the 1992 Plan and in the total number and
class of shares as to which awards may be made under the 1992 Plan.
Change of Control. Under the 1992 Plan, upon a Change of Control, each
outstanding option and SAR will automatically become exercisable in full for
the total remaining number of shares covered thereby. In addition, during the
90-day period following a Change of Control an optionee may choose to receive
cash equal to the difference between the exercise price of the option and the
fair market value of a share of ATL Common Stock determined as described above
for a limited SAR, in lieu of exercising the option and paying the option
price. Also, all restrictions on shares of restricted stock will lapse upon a
Change of Control, and performance units will be paid pro rata to the date of
a Change of Control and all amounts otherwise deferred by the Company and any
employee in connection with performance units will be distributed. A Change of
Control is defined in the 1992 Plan as (i) a change in the Board of Directors
such that a majority of the seats on the Board are occupied by individuals who
were neither nominated by a majority of the Incumbent Directors (as defined
below) of the Company then in office nor appointed by directors so nominated,
(ii) the acquisition by any person (other than the Company or an ATL employee
benefit plan) of, in the case of transactions not approved by a majority of
the directors of the Company who were either nominated by a majority of the
directors of the Company then in office or appointed by directors so nominated
("Incumbent Directors"), 20% or more of the combined general voting power of
the Common Stock and any other voting securities of the Company and, in the
case of other transactions, 33% or more of such combined voting power, or
(iii) the approval by the stockholders of the Company of a complete
liquidation or dissolution of the Company or a merger, consolidation or sale
of substantially all of the assets of the Company (collectively, a "Business
Combination"), other than a Business Combination in which all or substantially
all of the stockholders of the Company receive 60% or more of the stock of the
corporation resulting from the Business Combination in substantially the same
proportions as their ownership before the Business Combination, no holder has
more than 20% of the combined voting power of the capital stock of the
resulting corporation and at least a majority of the board of directors of the
resulting corporation are Incumbent Directors.
Administration. The Compensation Committee administers the 1992 Plan and
consists of at least three members of the Board who have not been eligible to
receive awards under the 1992 Plan or any other discretionary plans of the
Company or its affiliates for one year prior to their service on the
Compensation Committee.
18
<PAGE>
Amendment and Termination. The 1992 Plan may be terminated, modified or
amended by the stockholders of ATL. The Board of Directors may also terminate
the 1992 Plan, or modify or amend it in certain respects as set forth in the
1992 Plan. No options or awards may be granted under the 1992 Plan after June
26, 2002.
Federal Income Tax Consequences--Option Plans. The Federal income tax
consequences to the Company and to any person granted an award under the 1992
Plan, or under the proposed Nonemployee Director Plan (see PROPOSAL 3, below)
under the existing applicable provisions of the Code and the regulations
thereunder, are substantially as follows.
Under present law and regulations, no income will be recognized by a
participant upon the grant of stock options, SARS, restricted stock (except as
described below) or performance units.
On the exercise of a Nonqualified Stock Option, the optionee will recognize
taxable ordinary income in an amount equal to the excess of the fair market
value of the shares acquired over the option price. Upon a later sale of those
shares, the optionee will have short-term or long-term capital gain or loss,
as the case may be, in an amount equal to the difference between the amount
realized on such sale and the tax basis of the shares sold. If payment of the
option price is made entirely in cash, the tax basis of the shares will be
equal to their fair market value on the date of exercise (but not less than
the option price), and their holding period will begin on the day after the
exercise date.
If the optionee uses previously owned shares to exercise an option in whole
or in part the transaction will not be considered to be a taxable disposition
of the previously owned shares. The optionee's tax basis and holding period of
the previously owned shares will be carried over to the equivalent number of
shares received on exercise. The tax basis of the additional shares received
upon exercise will be the fair market value of the shares on the date of
exercise (but not less than the amount of cash, if any, used in payment), and
the holding period for such additional shares will begin on the day after the
exercise date.
The same rules apply to an Incentive Stock Option which is exercised more
than three months after the optionee's termination of employment (or more than
12 months thereafter in the case of permanent and total disability as defined
in the Code).
On the exercise of an Incentive Stock Option during employment or within
three months after the employee's termination of employment (12 months in the
case of permanent and total disability as defined in the Code), for regular
tax purposes the optionee will recognize no income at the time of exercise
(although the employee will have income for alternative minimum income tax
purposes at that time as if the option were a Nonqualified Stock Option) and
no deduction will be allowed to the Company for Federal income tax purposes in
connection with the grant or exercise of the option. If the acquired shares
are sold or exchanged after the later of (a) one year from the date of
exercise of the option, or (b) two years from the date of grant of the option
(the "Holding Period"), the difference between the amount realized by the
holder on that sale or exchange and the option price will be taxed to the
holder as a long-term capital gain or loss. If the shares are disposed of
before the Holding Period requirements are satisfied, then the holder will
recognize taxable ordinary income in the year of disposition in an amount
equal to the excess, on the date of exercise of the option, of the fair market
value of the shares received over the option price paid (or generally, if
less, the excess of the amount realized on the sale of the shares over the
option price), and the holder will have capital gain or loss, long-term or
short-term as the case may be, in an amount equal to the difference between
(x) the amount realized by the holder upon that disposition of the shares and
(y) the option price paid by the holder increased by the amount of ordinary
income, if any, so recognized by the holder.
Upon the receipt of restricted stock, the employee will generally recognize
taxable ordinary income when the shares cease to be subject to restrictions
under the plan equal to the excess of the fair market value of the shares at
that time over the amount, if any, paid for such shares. However, within 30
days after the date the shares are received, the employee may elect under
Section 83 (b) of the Code to recognize taxable ordinary income at the time of
transfer in an amount equal to the excess of the fair market value of the
shares at such
19
<PAGE>
time over the amount, if any, paid for such shares. In that case no additional
income will be recognized by the employee upon the lapse of restrictions on
the shares, but, if the shares are subsequently forfeited, the employee may
not deduct the income recognized at the time of receipt of the shares and the
employee will have a capital loss equal to the amount, if any, paid for such
shares. The recipient's holding period for the shares will begin at the time
taxable income is recognized under these rules, and the tax basis in the
shares will be the amount of ordinary income so recognized plus the amount, if
any, paid for the shares. Any dividends received on the restricted shares
prior to the date the employee recognizes income as described above will be
taxable compensation income when received.
Upon payment to a participant in settlement of a stock option or pursuant to
the exercise of SARs or pursuant to a performance unit award the participant
will recognize taxable ordinary income in an amount equal to the cash and the
fair market value of Common Stock received. Upon the issuance of a stock bonus
award the recipient will recognize taxable ordinary income in an amount equal
to the fair market value of the Common Stock received and the amount of any
tax offset cash award made together with the issuance of such stock.
Special rules apply to a Director or officer subject to liability under
Section 16(b) of the Securities and Exchange Act.
In all the foregoing cases the Company will generally be entitled to a
deduction at the same time and in the same amount as the optionee recognizes
ordinary income.
The Board of Directors has unanimously approved the amendment to the 1992
Plan and recommends a vote "FOR" approval of Proposal 2.
PROPOSAL 3: AMENDMENT TO NONEMPLOYEE DIRECTOR STOCK OPTION PLAN
Nonemployee Director Stock Option Plan. The Company's Amended Nonemployee
Director Stock Option Plan (the "Director Plan") was adopted by the Board of
Directors and approved by the shareholders in 1993. The Director Plan was
amended by the shareholders in 1995. The Director Plan provides for the
automatic annual grant of an option to purchase shares of Common Stock to each
nonemployee Director of the Company. The timing and number of shares which are
the subject of these grants are not determined by the Board, but have been
established by the shareholders. The Director Plan covers Directors of the
Company who are not otherwise employed by the Company or any parent or
subsidiary corporation, each of whom automatically receives the grant of an
option under the Director Plan on July 1 of each year in which he serves as a
Director. As of the date of this Proxy Statement, the Company has five
nonemployee Directors. Assuming that each of such persons is re-elected as a
Director of the Company at the Annual Meeting and continues to serve as a
Director on July 1, 1996, each of Messrs. Cramer, Feigenbaum, Miller, Nudelman
and Woolf will be entitled to receive grants under the Director Plan.
Proposed Amendment. At the date of this Proxy Statement, only 9,000 shares
of Common Stock remain to be issued under the Director Plan. At the Annual
Meeting, the shareholders of the Company will be asked to approve an amendment
to the Director Plan, which, if approved, will increase the number of shares
to be issued under the Plan by 55,000 shares of Common Stock. The purpose of
the proposed amendment is to continue to provide incentives that management
believes are necessary in order to attract and retain highly qualified and
experienced outside Directors, and to provide nonemployee Directors with
incentives that are closely aligned with shareholder interests and value.
Description of the Director Plan. The Director Plan currently authorizes a
total of 50,000 shares of Common Stock that may be subject to option grants,
subject to certain adjustments for reclassifications, reorganizations and
similar corporate transactions. Since only 9,000 shares of this original Plan
allocation remain, it is proposed to increase the total number of shares
authorized for issuance under the Plan to 105,000 shares.
Pursuant to the Director Plan, each nonemployee Director will automatically
receive annually, on first day of July, an option to purchase 5,000 shares of
Common Stock, at an exercise price equal to the fair market value
20
<PAGE>
of the Common Stock on the date of grant. The options vest upon the optionee's
continued service as a Director until the first anniversary of the date of
grant. Each option expires on the earlier of five years from the date of grant
or one year after a Director's termination of service as a Director. The
optionee's right to the stock options may not be assigned or transferred
except by will or applicable laws of descent and distribution or to a
designated beneficiary. If during the term of an option, there is a change in
the outstanding stock of the Company by reason of stock dividends, stock
splits, recapitalization, mergers, consolidation, combinations or exchanges of
shares, split-ups, split-offs, spin-offs, or other similar changes in
capitalization, or any distribution to stockholders other than cash dividends,
the number of and class of shares covered by any outstanding option and the
exercise price per share of the option will be proportionally adjusted.
Immediately prior to certain mergers, consolidations, liquidations or similar
reorganizations of the Company, any option granted under the Director Plan may
be exercised in whole or in part, whether or not the vesting requirements
applicable to such options have been satisfied.
The Director Plan is administered by the Board of Directors, which may
amend, terminate or suspend the Director Plan in certain limited respects;
provided, however, that if required to qualify the Director Plan under SEC
Rule 16b-3, no amendment may be made more than once every six months that
would change the amount, price, timing or vesting of Options, other than to
comport with changes in the Internal Revenue Code of 1986, as amended, or the
rules and regulations promulgated thereunder. If required to qualify the
Director Plan under Rule 16b-3, no amendment may be made without approval by
the Company's shareholders that would (a) materially increase the number of
shares of Common Stock that may be issued under the Director Plan, (b)
materially modify the requirements as to eligibility for participation in the
Director Plan, or (c) otherwise materially increase the benefits accruing to
participants under the Director Plan.
The Director Plan may be terminated, modified, or amended by the
shareholders of the Company. The Board of Directors may also terminate the
Director Plan, or modify or amend it in certain limited respects.
As of the date of this Proxy Statement, Messrs. Cramer, Feigenbaum, Miller,
Nudelman and Woolf are entitled to grants under the Director Plan.
Federal Tax Consequences. The federal income tax consequences to any person
granted an award under the Nonemployee Director Plan is described under
"Proposal 2: Amendment of ATL's 1992 Option, Stock Appreciation Right,
Restricted Stock, Stock Grant and Performance Unit Plan--Federal Income Tax
Consequences--Option Plans".
Those members of the Board of Directors who are not outside Directors and
are not beneficiaries under the Director Plan have unanimously approved the
amendment to the Amended Nonemployee Director Stock Option Plan and recommend
a vote "FOR" approval of Proposal 3.
PROPOSAL 4: RATIFICATION OF APPOINTMENT OF AUDITORS
Unless instructed to the contrary, it is intended that votes be cast
pursuant to the accompanying proxy for the ratification of the appointment of
KPMG Peat Marwick LLP as independent auditors of the Company for the year
1996. KPMG Peat Marwick has audited the accounts of the Company from 1987
through 1995. Representatives of KPMG Peat Marwick are expected to attend the
meeting and will have an opportunity to make a statement and/or to respond to
appropriate questions from stockholders.
In the event this ratification of the appointment of auditors is not made by
a majority of the shares present in person or by proxy and entitled to vote
thereon, the selection of other auditors will be considered and determined by
the Board of Directors.
The Board of Directors has unanimously approved the appointment of KPMG Peat
Marwick as auditors for the Company and its major subsidiaries for 1996 and
recommends a vote "FOR" approval of Proposal 4.
21
<PAGE>
EXPENSES OF SOLICITATION
The accompanying proxy is solicited by and on behalf of the Board whose
notice of meeting is attached to this Proxy Statement, and the entire cost of
such solicitation will be borne by the Company. Georgeson & Co., New York, New
York, will distribute proxy materials to beneficial owners and solicit proxies
by personal interview, mail, telephone and telegram, and will request
brokerage houses and other custodians, nominees and fiduciaries to forward
soliciting material to the beneficial owners of the Common Stock held on the
record date by such persons. The Company will pay Georgeson & Co. a fee of
$7,000.00 covering its services and will reimburse Georgeson & Co. for
payments made to brokers and other nominees for its expenses in forwarding
soliciting material. Solicitation by personal interview, telephone and
telegram by Directors, officers and other employees of ATL will be without
special compensation.
OTHER MATTERS
The Company knows of no other matters which are likely to be brought before
the meeting. If, however, other matters not now known or determined come
before the meeting, the persons named in the enclosed proxy or their
substitutes will vote such proxy in accordance with their judgment in such
matters.
PROPOSALS OF SHAREHOLDERS
In order for proposals of shareholders to be considered for inclusion in the
Proxy Statement and proxy for the 1996 Annual General Meeting of Shareholders,
said proposals must be received by the Secretary of ATL by December 2, 1996.
ANNUAL REPORT AND FORM 10-K
A copy of the Company's 1995 Annual Report is being mailed with this Proxy
Statement to each shareholder of record. Shareholders not receiving a copy the
such Annual Report to Shareholders may obtain one without charge by writing or
calling Corporate and Investor Relations, 22100 Bothell Everett Highway, P.O.
Box 3003, Bothell, WA 98041-3003, (206) 487-7000.
A copy of the Company's Annual Report on Form 10-K for the year ended
December 31, 1995, as filed with the Securities and Exchange Commission, will
be provided without charge to each shareholder of record who submits a written
request therefor addressed to ATL Corporate and Investor Relations, 22100
Bothell Everett Highway, P.O. Box 3003, Bothell, WA 98041-3003, (206) 487-
7000.
By order of the Board of Directors
/s/ W. Brinton Yorks, Jr.
W. Brinton Yorks, Jr.
Secretary and General Counsel
22
<PAGE>
P R O X Y
ADVANCED TECHNOLOGY LABORATORIES, INC.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned appoints DENNIS C. FILL, KIRBY L. CRAMER and HARRY WOOLF,
Ph.D., or any one of them, Proxies with full power of substitution, to vote the
shares of Advanced Technology Laboratories, Inc. which the undersigned is enti-
tled to vote at the Annual General Meeting of Shareholders of Advanced Technol-
ogy Laboratories, Inc., to be held on Wednesday, May 8, 1996, at 9:30 a.m. at
the Four Seasons Olympic Hotel, 411 University Street, Seattle Washington, and
at any adjournment thereof, on the matters set forth on the reverse side.
THE MATTERS TO BE VOTED UPON, THE INSTRUCTIONS AND A SPACE FOR YOUR VOTE AND
SIGNATURE ARE SET FORTH ON THE REVERSE SIDE.
If this Proxy relates to shares held for the undersigned in the Advanced Tech-
nology Laboratories, Inc. Incentive Savings and Stock Ownership Plan or the
SpaceLabs Medical, Inc. Incentive Savings and Stock Ownership Plan, then when
properly executed, it shall constitute instructions to the plan's trustees to
vote in the manner directed herein.
YOU ARE ENCOURAGED TO SPECIFY YOUR CHOICES BY MARKING THE APPROPRIATE BOXES
(SEE REVERSE SIDE), BUT YOU NEED NOT MARK ANY BOXES IF YOU WISH TO VOTE IN
ACCORDANCE WITH THE BOARD OF DIRECTORS' RECOMMENDATIONS. THE PROXIES CANNOT
VOTE YOUR SHARES UNLESS YOU SIGN AND RETURN THIS CARD.
SEE REVERSE
SIDE
- -------------------------------------------------------------------------------
[X] Please mark your votes as in this example. 9868
----
THIS PROXY WILL BE VOTED AS DIRECTED BY THE SHAREHOLDER(S); IF NOT OTHERWISE
SPECIFIED, THIS PROXY WILL BE VOTED "FOR" PROPOSALS 1, 2, 3 AND 4, AND IN THE
DISCRETION OF THE PROXIES UPON ANY OTHER MATTER WHICH MAY PROPERLY COME BEFORE
THE MEETING.
- --------------------------------------------------------------------------------
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1, 2, 3 AND 4:
- --------------------------------------------------------------------------------
1. Election of Directors
FOR [_] WITHHELD [_]
Nominees: Kirby L. Cramer, Harvey Feigenbaum, Dennis C. Fill, Eugene A. Larson,
John R. Miller, Phillip M. Nudelman and Harry Woolf.
For, except vote withheld from the following nominee(s):
- --------------------------------------------------------
2. AMENDMENT TO 1992 PLAN. Approve an amendment to increase the number of
shares available for issuance under the 1992 Plan by 550,000 shares.
FOR [_] AGAINST [_] ABSTAIN [_]
3. AMENDMENT TO NONEMPL0YEE DIRECTOR STOCK OPTION PLAN. Approve an amendment to
increase the number of shares available for issuance under the Director Plan
by 55,000 shares.
FOR [_] AGAINST [_] ABSTAIN [_]
4. RATIFICATION OF AUDITORS. Ratification of the appointment of KPMG Peat
Marwick LLP as independent auditors for the year ending December 31, 1996.
FOR [_] AGAINST [_] ABSTAIN [_]
SIGNATURE(S) _______________________________________DATE ______________________
Please date and sign your name(s) exactly as it appears hereon. When signing as
attorney, executor, administrator, trustee or guardian, please give full title
as it appears hereon. Second signature if stock jointly held.
<PAGE>
APPENDIX A
ADVANCED TECHNOLOGY LABORATORIES, INC.
AMENDED 1992 OPTION, STOCK APPRECIATION RIGHT, RESTRICTED STOCK, STOCK GRANT
AND PERFORMANCE UNIT PLAN
[PROPOSED]
1. DEFINITIONS
The following terms have the corresponding meanings for purposes of the Plan:
"Award Cycle" means a period of not less than three fiscal years over which
performance units granted during a particular year are to be earned out.
"Change of Control" means
(a) a "Board Change." For purposes of the Plan, a Board Change shall have
occurred if a majority of the seats (other than vacant seats) on the
Corporation's Board of Directors (the "Board") were to be occupied by
individuals who were neither (i) nominated by a majority of the Incumbent
Directors nor (ii) appointed by directors so nominated. An "Incumbent Director"
is a member of the Board who has been either (i) nominated by a majority of the
directors of the Corporation then in office or (ii) appointed by directors so
nominated, but excluding, for this purpose, any such individual whose initial
assumption of office occurs as a result of either an actual or threatened
election contest (as such terms are used in Rule 14a-11 of Regulation 14A
promulgated under the Securities Exchange Act of 1934, as amended (the
"Exchange Act") ) or other actual or threatened solicitation of proxies or
consents by or on behalf of a Person other than the Board; or
(b) The acquisition by any individual, entity or group (within the meaning of
Section 13 (d) (3) or 14(d) (2) of the Exchange Act) (a "Person") of
"Beneficial Ownership" (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of (i) 20% or more of either (A) the then outstanding shares of
common stock (the "Outstanding Corporation Common Stock") or (B) the combined
voting power of the then outstanding voting securities of the Corporation
entitled to vote generally in the election of directors (the "Outstanding
Corporation Voting Securities"), in the case of either (A) or (B) of this
clause (i), which acquisition is not approved in advance by a majority of the
Incumbent Directors or (ii) 33% or more of either (A) the Outstanding
Corporation Common Stock or (B) the Outstanding Corporation Voting Securities,
in the case of either (A) or (B) of this clause (ii), which acquisition is
approved in advance by a majority of the Incumbent Directors; provided,
however, that the following acquisitions shall not constitute a Change of
Control: (x) any acquisition by the Corporation, (y) any acquisition by any
employee benefit plan (or related trust) sponsored or maintained by the
Corporation or any corporation controlled by the Corporation, or (z) any
acquisition by any corporation pursuant to a reorganization, merger or
consolidation, if, following such reorganization, merger or consolidation, the
conditions described in clauses (i), (ii) and (iii) of the following subsection
(c) are satisfied; or
(c) Approval by the stockholders of the Corporation of a reorganization,
merger or consolidation, in each case, unless, following such reorganization,
merger or consolidation, (i) more than 60% of, respectively, the then
outstanding shares of common stock of the corporation resulting from such
reorganization, merger or consolidation and the combined voting power of the
then outstanding voting securities of such corporation entitled to vote
generally in the election of directors is then beneficially owned, directly or
indirectly, by all or substantially all of the individuals and entities who
were the beneficial owners, respectively, of the Outstanding Corporation Common
Stock and Outstanding Corporation Voting Securities immediately prior to such
reorganization, merger or consolidation in substantially the same proportions
as their ownership, immediately prior to such reorganization, merger or
consolidation, of the Outstanding Corporation Common Stock and Outstanding
Corporation Voting Securities, as the case may be, (ii) no Person (excluding
the Corporation, any employee benefit plan (or related trust) of the
Corporation or such corporation resulting from such reorganization, merger or
consolidation and any Person beneficially owning, immediately prior to
A-1
<PAGE>
such reorganization, merger or consolidation, directly or indirectly, 33% or
more of the Outstanding Corporation Common Stock or Outstanding Corporation
Voting Securities, as the case may be) beneficially owns, directly or
indirectly, 33% or more of, respectively, the then outstanding shares of common
stock of the corporation resulting from such reorganization, merger or
consolidation or the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in the election of
directors, and (iii) at least a majority of the members of the board of
directors of the corporation resulting from such reorganization, merger or
consolidation were Incumbent Directors at the time of the execution of the
initial agreement providing for such reorganization, merger or consolidation;
or
(d) Approval by the stockholders of the Corporation of (i) a complete
liquidation or dissolution of the Corporation or (ii) the sale or other
disposition of all or substantially all of the assets of the Corporation, other
than to a corporation, with respect to which following such sale or other
disposition, (A) more than 60% of, respectively, the then outstanding shares of
common stock of such corporation and the combined voting power of the then
outstanding voting securities of such corporation entitled to vote generally in
the election of directors is then beneficially owned, directly or indirectly,
by all or substantially all of the individuals and entities who were the
beneficial owners, respectively, of the Outstanding Corporation Common Stock
and Outstanding Corporation Voting Securities immediately prior to such sale or
other disposition in substantially the same proportion as their ownership,
immediately prior to such sale or other disposition, of the Outstanding
Corporation Common Stock and Outstanding Corporation Voting Securities, as the
case may be, (B) no Person (excluding the Corporation and any employee benefit
plan (or related trust) of the Corporation or such corporation and any Person
beneficially owning, immediately prior to such sale or other disposition,
directly or indirectly, 33% or more of the Outstanding Corporation Common Stock
or Outstanding Corporation Voting Securities, as the case may be) beneficially
owns, directly or indirectly, 33% or more of, respectively, the then
outstanding shares of common stock of such corporation and the combined voting
power of the then outstanding voting securities of such corporation entitled to
vote generally in the election of directors, and (C) at least a majority of the
members of the board of directors of such corporation were approved by a
majority of the Incumbent Directors at the time of the execution of the initial
agreement or action of the Board providing for such sale or other disposition
of assets of the Corporation.
"Committee" means the Committee provided for in Section 4, which shall
administer the Plan.
"Common Stock" means common stock, par value $0.01 per share, of the
Corporation.
"Corporation" means Advanced Technology Laboratories, Inc., a Delaware
corporation.
"Designated Beneficiary" means any person designated in writing by a
Participant as a legal recipient of payments due under an award in the event of
the Participant's death, or in the absence of such designation, the
Participant's estate. Such designation must be on file with the Corporation in
order to be effective but, unless the Participant has made an irrevocable
designation, may be changed from time to time by the Participant.
"Fair Market Value" of the Common Stock as of any trading day means the
average (rounded to the next highest cent in the case of fractions of a cent)
of the high and low sales prices of the Common Stock as reported on such
trading day by the NASDAQ National Market System. If no sales price is reported
for the Common Stock on such trading day, then "Fair Market Value" shall mean
the highest bid price reported for the Common Stock on such trading day by the
National Quotation Bureau Incorporated or any similar nationally recognized
organization. The Committee, in its sole discretion, shall make all
determinations required by this definition.
"Participant" means an employee, consultant or independent contractor who has
received an award under the Plan.
"Payment Schedule" means the schedule adopted by the Committee in accordance
with Section 10 with respect to an Award Cycle to govern determination of the
Payment Value of a performance unit at the end of such Award Cycle in
accordance with Section 10.
A-2
<PAGE>
"Payment Value" means the value, expressed in dollars, of a performance unit
at the conclusion of an Award Cycle, determined in accordance with Section 10.
"Plan" means this Advanced Technology Laboratories, Inc. 1992 Option, Stock
Appreciation Right, Restricted Stock, Stock Grant and Performance Unit Plan.
"Restricted Stock" means the shares of Common Stock referred to in Section 8.
"Retirement" means the termination of the services of a Participant because
of early or normal retirement as defined in the Westmark Retirement Plan.
"Withholding Tax" means any tax, including any federal, state or local income
tax, required by any governmental entity to be withheld or otherwise deducted
and paid with respect to the transfer of shares of Common Stock as a result of
the exercise of a Nonqualified Stock Option or stock appreciation right, the
payment of performance units or the award of Restricted Stock or stock grants.
2. STOCK SUBJECT TO THE PLAN
There are reserved for issuance upon the exercise of options, for issuance of
Restricted Stock and stock grant awards and for issuance upon the payment of
performance units and stock appreciation rights under the Plan [2,700,000]
shares of Common Stock, of which no more than an aggregate of [700,000] shares
may be issued as Restricted Stock awards and stock grants under the Plan. Such
shares may be authorized and unissued shares of Common Stock or previously
outstanding shares of Common Stock then held in the Corporation's treasury. If
any option or stock appreciation right granted under the Plan shall expire or
terminate for any reason (including, without limitation, by reason of its
surrender, pursuant to the provisions of Section 6(f) or the third paragraph of
Section 6(b) or otherwise, or cancellation, in whole or in part, pursuant to the
provisions of Section 6(c) or otherwise or pursuant to Section 7(f), or the
substitution in place thereof of a new option or stock appreciation right)
without having been exercised in full, the shares subject thereto shall again be
available for the purposes of issuance under the Plan. If shares of Restricted
Stock shall be forfeited and returned to the Corporation pursuant to the
provisions of Section 8, such shares shall again be available for the purposes
of issuance under the Plan. In no event shall shares of Common Stock which,
under the Plan, are authorized to be used in payment of performance unit awards
be deemed to be unavailable for purposes of the Plan until such shares have been
issued in payment thereof in accordance with the provisions of Section 10(g).
Stock appreciation rights and performance unit awards providing for payments
only in cash are not subject to the overall limitations referred to above.
3. ADMINISTRATION
The Plan shall be administered by the Committee. Subject to the express
provisions of the Plan, the Committee shall have plenary authority, in its
discretion, to determine the individuals to whom, and the time or times at
which, performance units or Restricted Stock shall be awarded and stock
appreciation rights or options shall be granted (including, without limitation,
whether such options shall be Incentive Stock Options or Nonqualified Stock
Options or a combination thereof, as such terms are defined in Section 6(a))
and the number of units and/or shares to be covered by each such award or
grant. In making such determinations, the Committee may take into account the
nature of the services rendered by the respective Participants, their present
and potential contributions to the Corporation's success and such other factors
as the Committee in its discretion may deem relevant. Subject to the express
provisions of the Plan, the Committee shall have plenary authority to interpret
the Plan, to prescribe, amend and rescind rules and regulations relating to it,
to determine the terms and provisions of Restricted Stock, performance unit,
stock appreciation right and option agreements (which need not be identical)
and to make all other determinations necessary or advisable for the
administration of the Plan. The Committee's determinations of the matters
referred to in this Section 3 shall be conclusive. It is the intention of the
Corporation that the Plan and the administration hereof comply in all respects
with Section 16(b) of the Exchange Act, and the rules and regulations
promulgated thereunder,
A-3
<PAGE>
and if any Plan provision is later found not to be in compliance with Section
16(b), the provision shall be deemed null and void, and in all events the Plan
shall be construed in favor of its meeting the requirements of Rule 16b-3.
Notwithstanding anything in the Plan to the contrary, the Board, in its
absolute discretion, may bifurcate the Plan so as to restrict, limit or
condition the use of any provision of the Plan to persons who are subject to
Section 16 of the Exchange Act without so limiting or conditioning the Plan
with respect to other persons.
4. THE COMMITTEE
The Board shall designate a Committee of members of the Board which shall
meet the requirements of Section 16(b) of the Exchange Act. Currently, the
Committee shall consist solely of two or more members of the Board who are
disinterested. If at any time an insufficient number of disinterested directors
is available to serve on such Committee, interested directors may serve on the
Committee; however, during such time, no options, stock appreciation rights or
Restricted Stock shall be granted under the Plan to any person if the granting
of such options, stock appreciation rights or Restricted Stock would not meet
the requirements of Section 16(b) of the Exchange Act.
For purposes of this Section 4, a "disinterested director" is a person who
meets the definition of "disinterested person" as set forth in the rules and
regulations promulgated under Section 16(b) of the Exchange Act. Currently, a
disinterested director is a member of the Board who is not (and, during the 12-
month period preceding his appointment as a member of the Committee has not
been) granted or awarded stock, stock appreciation rights or other equity
securities of the Corporation or any affiliated corporation pursuant to the
Plan or any other plan of the Corporation or any affiliated corporation except
for formula plans (as such term is defined in Rule 16b-3 (c) (2) (ii) issued
under the Exchange Act) or ongoing securities acquisition plans (as described
in Rule 16b-3 (d) (2) (i) issued under the Exchange Act). The Committee shall
be appointed by the Board, which may from time to time appoint members of the
Committee in substitution for members previously appointed and may fill
vacancies, however caused, in the Committee. The Committee shall select one of
its members as its Chairman and shall hold its meetings at such times and
places as it may determine. A majority of its members shall constitute a
quorum. All determinations of the Committee shall be made by not less than a
majority of its members. Any decision or determination reduced to writing and
signed by all the members shall be fully as effective as if it had been made by
a majority vote at a meeting duly called and held. The Committee may appoint a
secretary, shall keep minutes of its meetings and shall make such rules and
regulations for the conduct of its business as it shall deem advisable.
5. ELIGIBILITY
The Committee may award performance units and Restricted Stock and grant
options and stock appreciation rights only to employees, consultants or
independent contractors (which term as used herein includes officers) of the
Corporation and of its present and future subsidiary corporations
("subsidiaries"). Any person eligible under the Plan may receive one or more
awards of performance units or Restricted Stock or one or more grants of
options or stock appreciation rights, or any combination thereof, as the
Committee shall from time to time determine, and such determinations may be
different as to different Participants and may vary as to different awards and
grants.
The maximum number of shares of Common Stock with respect to which an option
or options or a stock appreciation right or stock appreciation rights may be
granted to any eligible employee in any one fiscal year of the Company shall not
exceed ten percent of the aggregate number of shares of Common Stock authorized
for issuance under the plan (the "Maximum Annual Employee Grant").
6. OPTION GRANTS
(a) The Committee is authorized under the Plan, in its discretion, to issue
options as "Incentive Stock Options" (as defined in Section 422 of the United
States Internal Revenue Code of 1986, as amended (the "Code")) or as
"Nonqualified Stock Options" (all other options granted hereunder) and the
options shall be designated as Incentive Stock Options or Nonqualified Stock
Options in the applicable option agreement. The purchase price of the Common
Stock under each option granted under the Plan shall be determined by the
Committee but shall be not less than 100% of the Fair Market Value of the
Common Stock at the time such option is granted. Notwithstanding the previous
sentence, any Nonqualified Stock Option may provide
A-4
<PAGE>
that the purchase price be equal to the average Fair Market Value of the Common
Stock over any continuous period of trading days beginning and ending no more
than 30 business days before or after the date such option is granted.
(b) The Committee shall be authorized in its discretion to prescribe in the
option grant the installments, if any, in which an option granted under the
Plan shall become exercisable, provided that no option shall be exercisable
prior to the first anniversary of the date of grant thereof except as provided
in Sections 6(c), (d), (h), (i) and (j) or except as the Committee otherwise
determines. In no case may an option be exercised as to less than 100 shares at
any one time (or the remaining shares covered by the option if less than 100)
during the term of the option. The Committee shall also be authorized to
establish the manner of the exercise of an option. The term of each option
shall be not more than 10 years from the date of grant thereof.
In general, upon exercise, the option price is to be paid in full in cash;
however, the Committee can determine at the time the option is granted for
Incentive Stock Options or at any time prior to exercise for Nonqualified Stock
Options, that additional forms of payment will be permitted. To the extent
permitted by the Committee and applicable laws and regulations (including, but
not limited to, federal tax and securities laws and regulations and state
corporate law), an option may be exercised (i) in Common Stock owned by the
option holder having a Fair Market Value on the date of exercise equal to the
aggregate option price, or in a combination of cash and stock; provided,
however, that payment in stock shall not be made unless such stock shall have
been owned by the option holder for a period of at least three months prior
thereto; or (ii) by delivery of a properly executed exercise notice, together
with irrevocable instructions to a broker designated by the Corporation, all in
accordance with the regulations of the Federal Reserve Board, to deliver
promptly to the Corporation the amount of sale or loan proceeds to pay the
exercise price and any federal, state or local withholding tax obligations that
may arise in connection with the exercise.
In lieu of requiring an option holder to pay cash or stock and to receive in
turn certificates for shares of Common Stock upon the exercise of a
Nonqualified Stock Option, if the option so provides, the Committee may elect
to require the option holder to surrender the option to the Corporation for
cancellation as to all or any portion of the number of shares covered by the
intended exercise and receive in exchange for such surrender a payment, at the
election of the Committee, in cash, in shares of Common Stock or in a
combination of cash and shares of Common Stock, equivalent to the appreciated
value of the shares covered by the option surrendered for cancellation. Such
appreciated value shall be the difference between the option price of such
shares (as adjusted pursuant to Section 15) and the Fair Market Value of such
shares, which shall for this purpose be determined by the Committee taking into
consideration all relevant factors, but which shall not be less than the Fair
Market Value of such shares on the date on which the option holder's notice of
exercise is received by the Corporation. Upon delivery to the Corporation of a
notice of exercise of option, the Committee may avail itself of its right to
require the option holder to surrender the option to the Corporation for
cancellation as to shares covered by such intended exercise. The Committee's
right of election shall expire, if not exercised, at the close of business on
the fifth business day following the delivery to the Corporation of such
notice. Should the Committee not exercise such right of election, the delivery
of the aforesaid notice of exercise shall constitute an exercise by the option
holder of the option to the extent therein set forth, and payment for the
shares covered by such exercise shall become due immediately.
(c) In the event that a Participant's services for the Corporation or one of
its subsidiaries shall cease and the termination of such individual's service
is for cause, the option shall automatically terminate upon first notification
to the option holder of such termination of services, unless the Committee
determines otherwise, and such option shall automatically terminate upon the
date of such termination of services for all shares which were not purchasable
upon such date. For purposes of this Section 6(c), "cause" is defined as a
determination by the Committee that the option holder (i) has committed a
felony, (ii) has engaged in an act or acts of deliberate and intentional
dishonesty resulting or intended to result directly or indirectly in improper
material gain to or personal enrichment of the individual at the Corporation's
expense, or (iii) has willfully disobeyed the Corporation's appropriate rules,
instructions or orders, and such willful disobeyance has continued for a period
of 10 days following notice thereof from the Corporation.
A-5
<PAGE>
In the event of the termination of the services of the holder of an option
because of Retirement or disability, he may (unless such option shall have been
previously terminated pursuant to the provisions of the preceding paragraph or
unless otherwise provided in his option grant) exercise such option at any time
prior to the expiration of the option, (i) in the event of disability or normal
Retirement, to the extent of the number of shares covered by such option,
whether or not such shares had become purchasable by him at the date of the
termination of his services and (ii) in the event of early Retirement, to the
extent of the number of shares covered by such option at such time or times as
such option becomes purchasable by him in accordance with its terms. (Although
the option may be exercised after Retirement or disability, under Section 422
of the Code, if the option has been designated as an Incentive Stock Option, it
must be exercised within three months after the date of Retirement or one year
after the termination of employment due to disability in order to qualify for
incentive stock option tax treatment.)
In the event of the death of an individual to whom an option has been granted
under the Plan, while he is performing services for the Corporation or a
subsidiary, the option theretofore granted to him (unless his option shall have
been previously terminated pursuant to the provisions of this Section 6(c) or
unless otherwise provided in his option grant) may, subject to the limitations
described in Section 6(g), be exercised by his Designated Beneficiary, by his
legatee or legatees of the option under his last will, or by his personal
representatives or distributees, at any time within a period of one year after
his death, but not after the expiration of the option, to the extent of the
remaining shares covered by his option whether or not such shares had become
purchasable by such an individual at the date of his death. In the event of the
death of an individual (i) during the one-year period following termination of
his services or (ii) following termination of his services by reason of
Retirement or disability, then the option (if not previously terminated
pursuant to the provisions of this Section 6 (c) ) may be exercised during the
remainder of such one-year period or during the remaining term of the option,
respectively, by his Designated Beneficiary, by his legatee under his last
will, or by his personal representative or distributee, but only to the extent
of the number of shares purchasable by such Participant pursuant to the
provisions of Section 6(d) at the date of termination of his services.
In the event of the termination of the services of the holder of an option,
other than by reason of Retirement, disability or death, he may (unless his
option shall have been previously terminated pursuant to the provisions of this
Section 6(c) or unless otherwise provided in his option grant) exercise his
option at any time within one year after such termination, but not after the
expiration of the option, to the extent of the number of shares covered by his
option which were purchasable by him at the date of the termination of his
services, and such option shall automatically terminate upon the date of such
termination of services for all shares which were not purchasable upon such
date.
(d) Notwithstanding the foregoing provisions, the Committee may determine, in
its sole discretion, in the case of any termination of services, that the
holder of an option may exercise such option to the extent of some or all of
the remaining shares covered thereby whether or not such shares had become
purchasable by such an individual at the date of the termination of his
services and may exercise such option at any time prior to the expiration of
the original term of the option, except that such extension shall not cause any
Incentive Stock Option to fail to continue to qualify as an Incentive Stock
Option without the consent of the option holder. Options granted under the Plan
shall not be affected by any change of relationship with the Corporation so
long as the holder continues to be an employee, consultant or independent
contractor of the Corporation or of a subsidiary; however, a change in a
participant's status from an employee to a nonemployee (e.g., consultant or
independent contractor) shall result in the termination of an outstanding
Incentive Stock Option held by such participant in accordance with Section
6(c). The Committee, in its absolute discretion, may determine all questions of
whether particular leaves of absence constitute a termination of services;
provided, however, that with respect to incentive stock options, such
determination shall be subject to any requirements contained in the Code.
Nothing in the Plan or in any option granted pursuant to the Plan shall confer
on any individual any right to continue in the employ or other service of the
Corporation or any other person or interfere in any way with the right of the
Corporation or any other person to terminate his employment or other services
at any time.
A-6
<PAGE>
(e) The date of grant of an option pursuant to the Plan shall be the date
specified by the Committee at the time it grants such option, provided that
such date shall not be prior to the date of such action by the Committee and
that the price shall be determined in accordance with Section 6(a) on such
date. The Committee shall promptly notify a grantee of an award and a written
option grant shall promptly be duly executed and delivered by or on behalf of
the Corporation.
(f) The Committee shall be authorized, in its absolute discretion, to permit
option holders to surrender outstanding options in exchange for the grant of
new options or to require option holders to surrender outstanding options as a
condition precedent to the grant of new options. The number of shares covered
by the new options, the option price (subject to the provisions of Section
6(a)), the option period and other terms and conditions of the new options
shall all be determined in accordance with the Plan and may be different from
the provisions of the surrendered options.
(g) In the event an optionee is granted Incentive Stock Options that in the
aggregate entitle the optionee to purchase, in the first year such options
become exercisable (whether under their original terms or as a result of the
occurrence of an Acceleration Event, as defined below), Common Stock of the
Corporation, any parent corporation or any subsidiary of the Corporation having
a Fair Market Value (determined as of the time such options are granted) in
excess of $100,000, such portion in excess of $100,000 shall be treated as a
Nonqualified Stock Option. Such limitation shall not apply if the Internal
Revenue Service publicly rules, issues a private ruling to the Corporation, any
optionee of the Corporation or any legatee, personal representative or
distributee of an optionee or states in proposed, temporary or final
regulations that provisions which allow the full exercise of an optionee's
Incentive Stock Options upon the occurrence of the relevant Acceleration Event
do not violate Section 422(d) of the Code. An "Acceleration Event" means (i) a
determination of the Committee to allow an optionee to exercise his options in
full upon termination of his employment or other service as provided in Section
6(c) or (d), (ii) the death of an optionee while he is employed by the
Corporation or a subsidiary, (iii) any Change of Control, or (iv) the
optionee's termination of employment or other service under circumstances that
will allow him to exercise options not otherwise exercisable pursuant to
Section 6(j).
(h) Notwithstanding any contrary waiting period, installment period or other
limitation or restriction in any option agreement or in the Plan, in the event
of a Change of Control, each option outstanding under the Plan shall thereupon
become exercisable at any time during the remaining term of the option, but not
after the term of the option, to the extent of the number of shares covered by
the option, whether or not such shares had become purchasable by the
Participant thereunder immediately prior to such Change of Control, subject,
however, to the limitations described in Section 6(g), by the holder of the
option.
(i) Anything in the Plan to the contrary notwithstanding, during the 90-day
period from and after a Change of Control (x) an optionee (other than an
optionee who initiated a Change of Control in a capacity other than as an
officer or a Director of the Corporation) who is an officer or a Director of
the Corporation (within the meaning of Section 16 of the Exchange Act and the
rules and regulations promulgated thereunder) with respect to an option that
was granted at least six months prior to the date of exercise pursuant to this
sentence and is unaccompanied by a stock appreciation right and (y) any other
optionee who is not an officer or a Director with respect to an option that is
unaccompanied by a stock appreciation right shall, unless the Committee shall
determine otherwise at the time of grant, have the right, in lieu of the
payment of the full purchase price of the shares of Common Stock being
purchased under the option and by giving written notice to the Corporation, to
elect (within such 90-day period) to surrender all or part of the option to the
Corporation and to receive in cash an amount equal to the amount by which the
amount determined pursuant to Section 7(d) hereof on the date of exercise
(determined as if the optionee had exercised a limited stock appreciation right
on such date) shall exceed the purchase price per share under the option
multiplied by the number of shares of Common Stock granted under the stock
option as to which the right granted by this sentence shall have been
exercised. Such written notice shall specify the optionee's election to
purchase shares granted under the option or to receive the cash payment
referred to in the immediately preceding sentence.
A-7
<PAGE>
(j) Notwithstanding the foregoing provisions, the optionee's employment or
other contract with the Corporation may provide that upon termination of his
employment or other services for other than cause or for "good reason" (as
defined in his contract), all stock options shall become immediately
exercisable.
7. STOCK APPRECIATION RIGHTS
(a) Stock appreciation rights may be paid upon exercise in cash, Common Stock
or any combination thereof, as the Committee in its sole discretion may
determine. A stock appreciation right is an incentive award that permits the
holder to receive (per share covered thereby) an amount equal to the amount by
which the Fair Market Value of a share of Common Stock on the date of exercise
exceeds the Fair Market Value of such share on the date the stock appreciation
right was granted.
(b) The Committee may grant a stock appreciation right separately or in
tandem with a related option and may grant both "general" and "limited" stock
appreciation rights. A general stock appreciation right granted in tandem with
a related option will generally have the same terms and provisions as the
related option with respect to exercisability, and the base price of such a
stock appreciation right will generally be equal to the option price under the
related option. Upon the exercise of a tandem stock appreciation right, the
related option will be deemed to be exercised for all purposes of the Plan and
vice versa.
(c) A general stock appreciation right granted separately and not in tandem
with any option will have such terms as the Committee may determine. The base
price of a stand-alone stock appreciation right may not be less than the Fair
Market Value of the Common Stock, determined as in Section 6(a) in the case of
a Nonqualified Stock Option; the term of a stand-alone stock appreciation right
may not be greater than 10 years from the date it was granted.
(d) A limited stock appreciation right may be exercised only during the 90
calendar days immediately following the date of a Change in Control. For the
purpose of determining the amount payable upon exercise of a limited stock
appreciation right, the fair market value of the Common Stock will be equal to
the higher of (x) the highest Fair Market Value of the Common Stock during the
90-day period ending on the date the limited stock appreciation right is
exercised and (y) whichever of the following is applicable:
(i) the highest per share price paid in any tender or exchange offer
which is in effect at any time during the 90 calendar days preceding the
exercise of the limited right;
(ii) the fixed or formula price for the acquisition of shares of Common
Stock in a merger or similar agreement approved by the Corporation's
stockholders or Board, if such price is determinable on the date of
exercise; and
(iii) the highest price per share paid to any stockholder of the
Corporation in a transaction or group of transactions giving rise to the
exercisability of the limited right. In no event, however, may the holder
of a limited stock appreciation right granted in tandem with a related
Incentive Stock Option receive an amount in excess of the maximum amount
which will enable the option to continue to qualify as an Incentive Stock
Option without the consent of the Participant.
(e) Limited stock appreciation rights are payable only in cash. General
stand-alone stock appreciation rights are payable only in cash, unless the
Committee provides otherwise at the time of grant. General stock appreciation
rights granted in tandem with a related option are payable in cash, Common
Stock or any combination thereof, as determined in the sole discretion of the
Committee. Notwithstanding the foregoing, and to the extent required by Rule
16b-3 promulgated under Section 16(b) of the Exchange Act, a payment, in whole
or in part, of cash upon exercise of a stock appreciation fight may be made to
an optionee who is an officer or director of the Corporation (within the
meaning of Section 16 of the Exchange Act and the rules and regulations
promulgated thereunder) only if (i) the fight was granted at least six months
prior to the date of exercise (except that in the event of the death or
disability of the optionee prior to the expiration of the six month period,
this limitation shall not apply) and (ii) the optionee's election to receive
cash in settlement
A-8
<PAGE>
of the right and the exercise of the right are made (a) during the period
beginning on the third business day following the date of release for
publication of the quarterly or annual summary statements of sales and earnings
of the Corporation and ending on the twelfth business day following such date,
(b) six months prior to the date the stock appreciation right becomes taxable
or (c) during the 90-day period from and after a Change of Control.
(f) Unless otherwise provided by the Committee at the time of grant, the
provisions of Section 6 relating to the termination of the service of a holder
of an option shall apply equally, to the extent applicable, to the holder of a
stock appreciation right.
8. RESTRICTED STOCK AWARDS
(a) The consideration to be received for shares of Restricted Stock issued
hereunder out of authorized but unissued shares or out of treasury shares shall
be equal to cash in an amount equal to the par value thereof and past services
for the Corporation. The recipient of Restricted Stock shall be recorded as a
stockholder of the Corporation, at which time the Corporation, at its
discretion, may either issue a Restricted Stock Certificate or make a book
entry credit in the Corporation's stock ledger to evidence the award of such
Restricted Stock, and the Participant shall have, subject to the provisions
hereof, all the rights of a stockholder with respect to such shares and receive
all dividends or other distributions made or paid with respect to such shares;
provided, that the shares themselves, and any new, additional or different
shares or securities which the recipient may be entitled to receive with
respect to such shares by virtue of a stock split or stock dividend or any
other change in the corporate or capital structure of the Corporation, shall be
subject to the restrictions hereinafter described.
(b) During a period of years following the date of grant, as determined by
the Committee, which shall in no event be less than one year (the "Restricted
Period"), the Restricted Stock or any rights thereto may not be sold, assigned,
transferred, pledged, hypothecated or otherwise encumbered or disposed of by
the recipient, except in the event of death or the transfer thereof to the
Corporation under the provisions of the next succeeding paragraph. In the event
of the death or normal Retirement of the recipient during the Restricted
Period, such restrictions shall immediately lapse, and the recipient or, in the
case of the recipient's death, his Designated Beneficiary, the legatee under
his last will or his personal representative or distributee shall be free to
transfer, encumber or otherwise dispose of the Restricted Stock. In the event
of the early Retirement of the recipient during the Restricted Period, such
restrictions shall continue until they lapse in accordance with the terms of
the grant.
Except as provided in Section 8(c), in the event that, during the Restricted
Period, the service of the recipient by the Corporation or one of its
subsidiaries is terminated for any reason (including termination with or
without cause by the Corporation or such subsidiary or resignation by the
recipient), other than termination of service due to the Retirement or death of
the recipient, then the shares of Restricted Stock held by him shall be
forfeited to the Corporation and the recipient shall immediately transfer and
return to the Corporation the certificates, if any have been issued to him,
representing all the Restricted Stock and the recipient's rights as a
stockholder with respect to the Restricted Stock shall cease, effective with
such termination of service. Notwithstanding the foregoing, the recipient's
service contract with the Corporation may provide that upon termination of his
service for other than cause or for good reason, all Restricted Stock shall
cease to be subject to such restrictions.
A recipient's rights to Restricted Stock may not be assigned or transferred
except upon death by will, descent or distribution. In the event of any attempt
by the recipient to sell, exchange, transfer, pledge or otherwise dispose of
shares of Restricted Stock in violation of the provisions hereof, such shares
shall be forfeited to the Corporation.
(c) Notwithstanding the Restricted Period contained in the grant of
Restricted Stock, in the event of a Change of Control (as defined in Section
1), all restrictions on shares of Restricted Stock shall immediately lapse and
such Restricted Shares shall become immediately transferable and
nonforfeitable.
A-9
<PAGE>
(d) Notwithstanding anything contained in the Plan to the contrary, the
Committee may determine, in its sole discretion, in the case of any termination
of a recipient's service, that the restrictions on some or all of the shares of
Restricted Stock awarded to a recipient shall immediately lapse and such
Restricted Shares shall become immediately transferable and nonforfeitable.
9. STOCK GRANT AWARDS
(a) Each nonofficer employee of the Corporation is eligible to receive a
grant of Common Stock as a stock bonus (i) at the end of each fiscal year or
(ii) if the employee terminates prior to year-end, at the time of termination.
The number of shares to be granted shall be determined by setting a percentage
of the employee's salary at the fiscal year-end or time of termination and
dividing that amount by the price per share of the Common Stock or by any other
method determined by the Committee. For this purpose, the price for the Common
Stock shall be the Fair Market Value on the date of grant and each grant shall
be for full shares only; any fractional shares resulting from this calculation
shall be disregarded. The consideration to be received for shares of Common
Stock issued under this Section 9(a) shall be cash in an amount equal to the
par value thereof and past services for the Corporation.
(b) In addition, each recipient of a stock grant under Section 9(a) may be
granted a cash award at the time the shares are issued in an amount sufficient
to offset the recipient's estimated tax liabilities arising from the issuance
of the Common Stock under Section 9(a).
(c) Determinations regarding eligibility for grants under Section 9 (a), the
amount of individual grants of Common Stock, the amount of the cash offset
award, the interpretation of Section 9 and all other matters relating to the
administration of Section 9 are within the sole discretion of the Committee.
10. PERFORMANCE UNIT AWARDS
(a) Performance units which are awarded to a Participant shall have a "unit
base value," expressed in dollars, determined by the Committee on the day on
which the award is granted and generally determined to be the Fair Market Value
of the Common Stock on such day. The performance units will also have a Payment
Value at the end of the applicable Award Cycle contingent upon the performance
of the Corporation and/or of such Participant's subsidiary, division or
department during the Award Cycle. The performance measures may include, but
shall not be limited to, cumulative growth in earnings per share or pretax
profits, return on stockholders' equity, asset management, cash flow or return
on capital employed. Such measures may be applied on an absolute basis or
relative to industry indices and shall be defined in a manner which the
Committee shall deem appropriate. For each performance unit awarded, the
Committee shall determine the length of the Award Cycle, which shall be a
period of not less than three fiscal years, and shall establish a Payment
Schedule based upon the performance measures determined for such performance
unit and the length of the Award Cycle, setting forth a range of Payment Values
corresponding to performance levels targeted for the Corporation or such
subsidiary, division or department. If during the course of an Award Cycle
there should occur, in the opinion of the Committee, significant changes in
economic conditions or in the nature of the operations of the Corporation or a
subsidiary, division or department which the Committee did not foresee in
establishing the performance measures for such Award Cycle and which, in the
Committee's sole judgment have, or are expected to have, a substantial effect
on the performance of the Corporation or of a Participant's subsidiary,
division or department during such Award Cycle, the Committee may revise the
Payment Schedule and performance measures formerly determined by it in such
manner as the Committee, in its sole judgment, may deem appropriate except as
otherwise provided in Section 10(1).
(b) In determining the number of performance units to be awarded, the
Committee shall take into account a person's responsibility level, performance,
potential, cash compensation level and such other considerations as it deems
appropriate.
A-10
<PAGE>
(c) Except as otherwise provided in Section 10(1), an award of performance
units to a Participant shall terminate for all purposes if the services of the
Participant for the Corporation or one of its subsidiaries ceases during the
Award Cycle, except in the case of death, disability or retirement under the
Corporation's pension plan (including early retirement at the request of the
Corporation), in which case (and provided that the Participant at the time of
death, disability or retirement as aforesaid shall have maintained his
employment or other qualifying relationship with the Corporation or one of its
subsidiaries continuously during the period commencing on the date the award
was granted and ending on the first anniversary thereof) the Participant will
be entitled to payment (such payment to be made in accordance with the
provisions of Section 10(d)) of the same portion of the Payment Value of the
award the Participant would otherwise have been paid (such Payment Value, if
any, to be determined at the conclusion of the applicable Award Cycle in
accordance with the provisions of Sections 10(a) and 10(e) unless otherwise
provided in Section 10(1)) as the portion of the Award Cycle during which the
Participant maintained such relationship with the Corporation bears to the full
Award Cycle. Under particular circumstances, the Committee may make other
determinations with respect to Participants whose services do not meet the
foregoing requirements, including the waiver of any of the requirements of this
subsection (c) relating to periods of continuous service.
(d) Except as otherwise provided in Section 10(1), unless the Committee
otherwise determines, no payment with respect to performance units will be made
to a Participant prior to the end of such Participant's Award Cycle; provided,
however, that if a Participant should die during an Award Cycle and his award
shall not have been terminated hereunder prior to his death, such Participant's
Designated Beneficiary, the legatee under the Participant's last will, his
personal representative or his distributee may elect instead, subject to the
approval of the Committee, to have the pro rata portion of the Participant's
Payment Value determined by the Committee as of the end of the year during
which such Participant's death occurred, based upon application of the Payment
Schedule to the part of the Award Cycle which shall have elapsed (for such
purpose, the cumulative growth rate or improvement achieved in the applicable
performance measures to the end of the fiscal year in which death occurs will
be assumed to continue for the Award Cycle), in which event such pro rata
portion shall be paid in cash or Common Stock, as provided in Section 10(g), as
soon as practicable following such year (or in such number of installments as
shall have been requested by the Participant and approved by the Committee) to
such Participant's Designated Beneficiary or legal representative.
(e) Except as otherwise provided in Section 10 (d) in the case of death, or
in Section 10 (1) in the case of a Change in Control, a Participant's interest
in any performance units awarded to him shall mature on the last day of the
Award Cycle for such award. The Payment Value of a performance unit shall be
the dollar amount calculated on the basis of the Payment Schedule applicable to
such Award Cycle.
(f) The total amount of Payment Value due a Participant at the conclusion of
an Award Cycle shall be paid on such date following the conclusion of such
Award Cycle as the Committee shall designate, except as specifically otherwise
provided in the Plan; provided, however, that the Committee shall have
authority, if it deems appropriate, to defer payment (in cash or in stock or
both in specified percentages) of the Payment Value due a Participant if the
Participant shall request the Committee to do so at any time prior to the last
year of the Award Cycle for such award. In respect of awards made or to be made
in one or more deferred installments in cash, interest shall be credited
semiannually on each such award at a rate to be determined semiannually by the
Committee, but in no event shall such rate be less than the average rate on 10-
year AAA new industrial corporate bonds during each such semiannual period as
calculated on the basis of the average of such rates for each calendar week
ending during the period January 1 through June 30 and July 1 through December
31; provided that awards made during any such six-month period shall be
credited on the basis of the average rate for that period; and provided further
that installments paid during any six-month period shall be credited with
interest on the basis of the average rate for the next preceding six-month
period. in each case adjusted for the number of days such award was to be
credited. Unless paid to the recipient of such award at the time credited,
interest at the foregoing rate shall be credited on the interest so credited
until so paid. The foregoing minimum interest rate for any award that is
payable in one or more deferred installments under the Plan may not be modified
without the prior written consent of the Participant.
A-11
<PAGE>
Whenever an award is made in one or more deferred installments in Common
Stock, the Committee may determine that there shall be credited on such award
an amount equivalent to the dividends which would have been paid with respect
to such shares of Common Stock if they had been issued and outstanding. Such
dividend equivalents shall be credited on the dividend record dates until
certificates for such shares shall have been delivered to the recipient of such
award or until such earlier date as the Committee may determine.
Such interest and dividend equivalents shall be paid to the recipient of any
such award in cash (or in property if the related dividend shall have been in
property) at such time or times during the deferred period of such award or at
the same time as the cash or shares of Common Stock to which such interest and
dividend equivalents apply, all as the Committee shall determine. The Committee
may also determine that any such dividend equivalents may be used to purchase
additional shares of outstanding Common Stock (such shares to be valued for
such purpose at Fair Market Value on the dividend record date) to be added to
the shares of Common Stock covered by such award and held subject to the same
terms and conditions, including provisions relating to the payment of amounts
equivalent to dividends thereon.
(g) Except as otherwise provided in Section 10(1), the Committee in its
discretion may determine at the time of grant or at the end of the Award Cycle
as to each Participant whether the payment of the Payment Value due a
Participant shall be made (i) in cash, (ii) in shares of Common Stock (valued
at the average Fair Market Value of the Common Stock for the five trading days
immediately preceding the date of payment), or (iii) in a combination of cash
and shares of Common Stock so valued.
(h) If the payment of any award shall be deferred until after the termination
of the services of the recipient by the Corporation or one of its subsidiaries,
the cash or Common Stock covered by such award, together with any deferred
interest or dividend equivalents thereon, shall be delivered in not more than
20 annual installments, commencing not later than the January 31 after such
termination of services (or such other date as the Committee from time to time
shall determine), all as the Committee may determine. If the payment of an
award under the Plan is deferred, such payment thereafter may be accelerated so
that such payment shall be made immediately or at such earlier time or in such
less number of installments, in each case as the Committee may from time to
time determine, but only with the prior written consent of the Participant.
(i) A Participant to whom any award has been made shall not have any interest
beyond that of a general creditor of the Corporation in the cash or Common
Stock awarded, or in any interest or dividend equivalents credited to him until
the cash has been paid to him or the certificates for the Common Stock have
been delivered to him, as the case may be, in accordance with the provisions of
the Plan.
(j) In the case of the death of the recipient of an award, before or after
the termination of his services, any unpaid installments of such deferred award
shall pass to the Designated Beneficiary, the legatee under the Participant's
last will, his personal representative or his distributee. Unpaid installments
of a deferred award shall be paid either in the same installments as originally
provided or otherwise as the Committee may determine in individual cases.
(k) Subject to the provisions of Section 10 (1), in any case in which payment
of an award is to be made in Common Stock, the Corporation shall have the
right, in lieu of delivering the certificate or certificates for any or all of
the stock which would otherwise be deliverable to the Participant pursuant to
the Plan, to pay to such Participant on the date on which such certificate or
certificates would otherwise be deliverable an amount in cash equal to the Fair
Market Value of such Common Stock on such date or dates as may be determined by
the Committee, but not more than five trading days prior to such date, all as
the Committee may determine in individual cases.
(l) Anything herein to the contrary notwithstanding, in the event of a Change
of Control, with respect to any unmatured performance unit awards which a
Participant held immediately prior to such Change of
A-12
<PAGE>
Control, the Participant will be entitled to immediate payment in cash (unless
payment of such performance unit awards shall be deferred in accordance with
Section 10(f), in which event the amount provided to be payable by this Section
10(1) shall also be so deferred) in an amount equal to the value of such units
determined in accordance with the Payment Schedule applicable to such awards,
based on the cumulative growth rate in the Corporation's reported earnings per
share for all previously elapsed fiscal years, if any, included in the Award
Cycles for such awards and the actual or presumed cumulative growth rate in the
earnings per share for the balance of each Award Cycle, determined as follows:
(i) if such Change of Control occurs prior to the completion of the first
fiscal year of an Award Cycle, the cumulative growth rate to be utilized for
the balance of the Award Cycle shall be the cumulative growth rate in the
Corporation's earnings per share in the four fiscal years preceding the first
year and (ii) if such Change of Control occurs during any subsequent fiscal
year of an Award Cycle, the cumulative growth rate to be utilized for the
balance of the Award Cycle shall be the cumulative growth rate of the preceding
fiscal year(s) in that Award Cycle prior to the fiscal year in which occurs the
Change of Control. In the event that a performance measure other than earnings
per share is employed, similar adjustments shall be made for such holders of
unmatured performance units. The Committee may in its discretion determine that
such historical financial data are not appropriate or not available and may use
the latest budgets, projections, forecasts or plans for the Corporation or its
business units or subsidiaries. Except as expressly set forth in this Section
10(l), upon the occurrence of a Change of Control, no change(s) shall be made
in the terms of any performance unit (including, without limitation, its unit
base value, Payment Value or performance criteria) or in the underlying
accounting assumptions or practices for purposes of determining the amount due
thereunder, which change(s) would lessen the value of any performance unit to
the holder thereof.
11. WITHHOLDING TAXES
In connection with the transfer of shares of Common Stock as a result of the
exercise of a Nonqualified Stock Option or stock appreciation right, the
payment of performance units or the award of Restricted Stock or stock grants,
the Corporation (a) shall not issue a certificate for such shares until it has
received payment from the Participant of any Withholding Tax in cash or by the
retention or acceptance upon delivery thereof by the Participant of shares of
Common Stock sufficient in Fair Market Value to cover the amount of such
Withholding Tax and (b) shall have the right to retain or sell without notice,
or to demand surrender of, shares of Common Stock in value sufficient to cover
any Withholding Tax. The Corporation shall have the right to withhold from any
cash amounts due from the Corporation to the award recipient pursuant to the
Plan an amount equal to the Withholding Tax. In either case, the Corporation
shall make payment (or reimburse itself for payment made) to the appropriate
taxing authority of an amount in cash equal to the amount of such Withholding
Tax, remitting any balance to the Participant. For purposes of this Section 11,
the value of shares of Common Stock so retained or surrendered shall be equal
to the Fair Market Value of such shares on the date that the amount of the
Withholding Tax is to be determined (the "Tax Date"), and the value of shares
of Common Stock so sold shall be the actual net sale price per share (after
deduction of commissions) received by the Corporation.
Notwithstanding the foregoing, the Participant may elect, subject to approval
by the Committee, to satisfy the obligation to pay any Withholding Tax, in
whole or in part, by providing the Corporation with funds sufficient to enable
the Corporation to pay such Withholding Tax or by having the Corporation retain
or accept upon delivery thereof by the Participant shares of Common Stock
sufficient in Fair Market Value to cover the amount of such Withholding Tax.
Each election by a Participant to have shares retained or to deliver shares for
this purpose shall be subject to the following restrictions: (i) the election
must be in writing and made on or prior to the Tax Date and (ii) if the
Participant is subject to Section 16 of the Exchange Act, an election to have
shares retained to satisfy the Withholding Tax must be an irrevocable election
made at least six months prior to the Tax Date or the withholding election must
become effective during the ten-business day period beginning on the third
business day following the date on which the Corporation releases for
publication its annual or quarterly summary statements of sales and earnings
and ending on the twelfth business day following the date of release thereof.
A-13
<PAGE>
12. TRANSFERABILITY AND OWNERSHIP RIGHTS OF OPTIONS, STOCK APPRECIATION RIGHTS
AND PERFORMANCE UNITS
No option or stock appreciation fight granted or performance unit awarded
under the Plan shall be transferable otherwise than pursuant to the designation
of a Designated Beneficiary or by will, descent or distribution, and an option
or stock appreciation fight may be exercised, during the lifetime of the holder
thereof, only by him. The holder of an option, stock appreciation right or
performance unit award shall have none of the fights of a stockholder until the
shares subject thereto or awarded thereby shall have been registered in the
name of such holder on the transfer books of the Corporation.
13. HOLDING PERIODS
(a) If a director or officer subject to Section 16 of the Exchange Act sells
shares of Common Stock obtained upon the exercise of a stock option within six
months after the date the option was granted, the option grant will no longer
be exempt from Section 16(b) and will retroactively be deemed a nonexempt
purchase as of the date of the option grant.
(b) In order to obtain certain tax benefits afforded to incentive stock
options under Section 422 of the Code, an optionee must hold the shares issued
upon the exercise of an incentive stock option for two years after the date of
grant of the option and one year from the date of exercise. An optionee may be
subject to the alternative minimum tax at the time of exercise of an incentive
stock option. The Committee may require an optionee to give the Corporation
prompt notice of any disposition in advance of the required holding period of
shares of Common Stock acquired by exercise of an incentive stock option. Tax
advice should be obtained when exercising any option and prior to the
disposition of the shares issued upon the exercise of any option.
14. SECTION 16(B) COMPLIANCE AND BIFURCATION OF PLAN
It is the intention of the Corporation that, if any of the Corporation's
equity securities are registered pursuant to Section 12(b) or 12(g) of the
Exchange Act, the Plan shall comply in all respects with Rule 16b-3 under the
Exchange Act and, if any Plan provision is later found not to be in compliance
with such Section, the provision shall be deemed null and void, and in all
events the Plan shall be construed in favor of its meeting the requirements of
Rule 16b-3. Notwithstanding anything in the Plan to the contrary, the Board, in
its absolute discretion, may bifurcate the Plan so as to restrict, limit or
condition the use of any provision of the Plan to participants who are officers
and directors subject to Section 16 of the Exchange Act without so restricting,
limiting or conditioning the Plan with respect to other participants.
15. ADJUSTMENTS UPON CHANGES IN CAPITALIZATION
Except as otherwise provided in Section 6(h) and Section 10(l), in the event
of any changes in the outstanding stock of the Corporation by reason of stock
dividends, stock splits, recapitalizations, mergers, consolidations,
combinations or exchanges of shares, split-ups, split-offs, spin-offs,
liquidations or other similar changes in capitalization, or any distribution to
stockholders other than cash dividends, the Committee shall make such
adjustments, if any, in light of the change or distribution as the Committee in
its sole discretion shall determine to be appropriate, (i) in the number and
class of shares or rights subject to options and stock appreciation rights and
the exercise prices of the options and stock appreciation rights covered
thereby and the Maximum Annual Employee Grant and (ii) in the number of shares
of Common Stock covered by a performance unit award for which certificates have
not been delivered, any dividend equivalents to which deferred awards of Common
Stock are entitled, and the performance measures established by the Committee
under Section 10(a). In the event of any such change in the outstanding Common
Stock of the Corporation, the aggregate number and class of shares available
under the Plan and the maximum number of shares as to which options may be
granted and stock appreciation rights or performance units awarded and the
maximum number of shares of Restricted Stock which may be awarded shall be
appropriately adjusted by the Committee.
A-14
<PAGE>
16. AMENDMENT AND TERMINATION
Unless the Plan shall theretofore have been terminated as hereinafter
provided, the Plan shall terminate on, and no awards of performance units,
stock appreciation rights, or Restricted Stock or options shall be made after,
June 26, 2002; provided, however, that such termination shall have no effect on
awards of performance units, stock appreciation rights, Restricted Stock or
options made prior thereto. The Plan may be terminated, modified or amended by
the stockholders of the Corporation. The Board of Directors of the Corporation
may also terminate the Plan, or modify or amend the Plan in such respects as it
shall deem advisable in order to conform to any change in any law or regulation
applicable thereto, or in other respects; however, to the extent required by
applicable law or regulation, stockholder approval will be required for any
amendment which will (a) materially increase the total number of shares as to
which options may be granted or which may be used in payment of performance
unit awards or stock appreciation right awards under the Plan or which may be
issued as Restricted Stock, (b) materially change the class of persons eligible
to receive awards of performance units or Restricted Stock and grants of stock
appreciation rights or options, (c) materially increase the benefits accruing
to participants under the Plan, or (d) otherwise require stockholder approval
under any applicable law or regulation. The amendment or termination of the
Plan shall not, without the consent of the recipient of any award under the
Plan, alter or impair any rights or obligations under any award theretofore
granted under the Plan.
17. EFFECTIVENESS OF THE PLAN
The Plan shall become effective on June 26, 1992. The Committee may in its
discretion authorize the awarding of performance units and Restricted Stock and
the granting of options and stock appreciation rights, the payments, issuance
or exercise of which, respectively, shall be expressly subject to the
conditions that (a) the shares of Common Stock reserved for issuance under the
Plan shall have been duly listed, upon official notice of issuance, upon each
stock exchange in the United States upon which the Common Stock is traded and
(b) a registration statement under the Securities Act of 1933, as amended, with
respect to such shares shall have become effective.
A-15
<PAGE>
ADVANCED TECHNOLOGY LABORATORIES, INC.
AMENDED NONEMPLOYEE DIRECTORS STOCK OPTION PLAN
[PROPOSED]
ARTICLE I PURPOSES
The purposes of the Advanced Technology Laboratories, Inc. Stock Option
Plan for Nonemployee Directors (the "Plan") are to attract and retain the
services of experienced and knowledgeable nonemployee directors of Advanced
Technology Laboratories, Inc. (the "Corporation") and to provide an incentive
for such directors to increase their proprietary interests in the Corporation's
long-term success and progress.
ARTICLE II SHARES SUBJECT TO THE PLAN
Subject to adjustment in accordance with Article VI hereof, the total
number of shares of the Corporation's common stock, $.0l par value per share
(the "Common Stock"), for which options may be granted under the Plan is
[105,000] (the "Shares"). The Shares shall be shares presently authorized but
unissued or subsequently acquired by the Corporation and shall include shares
representing the unexercised portion of any option granted under the Plan which
expires or terminates without being exercised in full.
ARTICLE III ADMINISTRATION OF THE PLAN
The administrator of the Plan (the "Plan Administrator") shall be the Board
of Directors of the Corporation (the "Board"). Subject to the terms of the
Plan, the Plan Administrator shall have the power to construe the provisions of
the Plan, to determine all questions arising thereunder and to adopt and amend
such rules and regulations for the administration of the Plan as it may deem
desirable. No member of the Plan Administrator shall participate in any vote by
the Plan Administrator on any matter materially affecting the rights of any such
member under the Plan.
ARTICLE IV PARTICIPATION IN THE PLAN
Each member of the Board elected or appointed who is not otherwise an
employee of the Corporation or any parent or subsidiary corporation (an
"Eligible Director") shall automatically receive the grant of an option
to purchase 5,000 Shares on the first day of July in each year that the Eligible
Director serves.
ARTICLE V OPTION TERMS
Each option granted to an Eligible Director under the Plan and the issuance
of Shares thereunder shall be subject to the following terms:
1. Option Agreement
Each option granted under the Plan shall be evidenced by an option
agreement (an "Agreement") duly executed on behalf of the Corporation. Each
Agreement shall comply with and be subject to the terms and conditions of the
Plan. Any Agreement may contain such other terms, provisions and conditions
not inconsistent with the Plan as may be determined by the Plan Administrator.
2. Option Exercise Price
The option exercise price for an option granted under the Plan shall be the
fair market value of the Shares covered by the option at the time the option is
granted. For purposes of the Plan, "fair market value" shall be the average of
the high and low sales prices at which the Common Stock was sold on such date
<PAGE>
as reported by the NASDAQ National Market System on such date or, if no Common
Stock was traded on such date, on the next preceding date on which Common Stock
was so traded.
3. Vesting and Exercisability
An option shall become fully vested and become nonforfeitable on July 1 of
the year following the year in which the option was granted if the optionee has
continued to serve as a Director until such date.
4. Time and Manner of Exercise of Option
Each option may be exercised in whole or in part at any time and from time
to time; provided, however, that no fewer than 100 Shares (or the remaining
Shares then purchasable under the option, if less than 100 Shares) may be
purchased upon any exercise of option rights hereunder and that only whole
Shares will be issued pursuant to the exercise of any option.
Any option may be exercised by giving written notice, signed by the person
exercising the option, to the Corporation stating the number of Shares with
respect to which the option is being exercised, accompanied by payment in full
for such Shares, which payment may be in whole or in part (i) in cash or by
check or (ii) in shares of Common Stock already owned for at least three (3)
months by the person exercising the option, valued at fair market value at the
time of such exercise.
5. Term of Options
Each option shall expire five (5) years from the date of the granting
thereof, but shall be subject to earlier termination as follows:
(a) In the event that an optionee ceases to be a director of the
Corporation for any reason other than the death of the optionee, the
options granted to such optionee may be exercised by him or her only within
one (1) year after the date such optionee ceases to be a director of the
Corporation.
(b) In the event of the death of an optionee, whether during the
optionee's service as a director or during the one (1) year period referred
to in Section 5 (a), the options granted to such optionee shall be
exercisable, and such options shall expire unless exercised within one (1)
year after the date of the optionee's death, by the legal representatives
or the estate of such optionee, by any person or persons whom the optionee
shall have designated in writing on forms prescribed by and filed with the
Corporation or, if no such designation has been made, by the person or
persons to whom the optionee's rights have passed by will or the laws of
descent and distribution.
6. Transferability
During an optionee's lifetime, an option may be exercised only by the
optionee. Options granted under the Plan and the rights and privileges
conferred thereby shall not be subject to execution, attachment or similar
process and may not be transferred, assigned, pledged or hypothecated in any
manner (whether by operation of law or otherwise) other than by will or by the
applicable laws of descent and distribution except that, to the extent
permitted by applicable law and Rule 16b-3 promulgated under Section 16(b) of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Plan
Administrator may permit a recipient of an option to designate in writing
during the optionee's lifetime a beneficiary to receive and exercise options in
the event of the optionee's death (as provided in Section 5(b)). Any attempt
to transfer, assign, pledge, hypothecate or otherwise dispose of any option
under the Plan or of any right or privilege conferred thereby, contrary to the
provisions of the Plan, or the sale or levy or any attachment or similar
process upon the rights and privileges conferred hereby, shall be null and
void.
7. Participant's or Successor's Rights as Stockholder
Neither the recipient of an option under the Plan nor the optionee's
successor(s) in interest shall have any rights as a stockholder of the
<PAGE>
Corporation with respect to any Shares subject to an option granted to such
person until such person becomes a holder of record of such Shares.
8. Limitation as to Directorship
Neither the Plan nor the granting of an option nor any other action taken
pursuant to the Plan shall constitute or be evidence of any agreement or
understanding, express on implied, that an optionee has a right to continue as
a director for any period of time or at any particular rate of compensation.
9. Regulatory Approval and Compliance
The Corporation shall not be required to issue any certificate or
certificates for Shares upon the exercise of an option granted under the Plan,
or record as a holder of record of Shares the name of the individual exercising
an option under the Plan, without obtaining to the complete satisfaction of the
Plan Administrator the approval of all regulatory bodies deemed necessary by
the Plan Administrator, and without complying, to the Plan Administrator's
complete satisfaction, with all rules and regulations under federal, state or
local law deemed applicable by the Plan Administrator.
ARTICLE VI CAPITAL ADJUSTMENTS
The aggregate number and class of Shares for which options may be granted under
the Plan, the number and class of Shares covered by each automatic grant and
each outstanding option and the exercise price per Share thereof (but not the
total price) shall all be proportionately adjusted for any stock dividends,
stock splits, recapitalizations, combinations or exchanges of shares, split-ups,
split-offs, spinoffs, or other similar changes in capitalization. Upon the
effective date of a dissolution or liquidation of the Corporation with one or
more corporations which results in more than eighty percent of the outstanding
voting shares of the Corporation being owned by one or more affiliated
corporations or other affiliated entities, or of a transfer of all or
substantially all the assets or more than eighty percent of the then outstanding
shares of the Corporation to another corporation or other entity, this Plan and
all options granted hereunder shall terminate. In the event of such
dissolution, liquidation, reorganization, merger, consolidation, transfer of
assets or transfer of stock, each optionee shall be entitled, for a period of
twenty days prior to the effective date of such transaction, to purchase the
full number of shares under his or her option which he or she is otherwise would
have been entitled to purchase during the remaining term of such option.
Adjustments under this Article IV shall be made by the Plan Administrator,
whose determination shall be final. In the event of any adjustment in the
number of Shares covered by any option, any fractional Shares resulting from
such adjustment shall be disregarded and each such option shall cover only the
number of full Shares resulting from such adjustment.
ARTICLE VII EXPENSES OF THE PLAN
All costs and expenses of the adoption and administration of the Plan shall
be borne by the Corporation; none of such expenses shall be charged to any
optionee.
ARTICLE VIII EFFECTIVE DATE AND DURATION OF THE PLAN
The Plan shall be effective on May 5, 1993. The Plan shall continue in
effect until it is terminated by action of the Board or the
Corporation's stockholders, but such termination shall not affect the
then-outstanding terms of any options.
ARTICLE IX TERMINATION AND AMENDMENT OF THE PLAN
The Board may amend, terminate or suspend the Plan at any time, in its sole
and absolute discretion; provided, however, that if required to qualify the Plan
under Rule 16b-3 promulgated under Section 16(b) of the Exchange Act, no
amendment may be made more than once every six (6) months that would change the
amount, price, timing or vesting of the options, other than to comport with
changes in the Internal Revenue Code of 1986, as amended, or the rules and
<PAGE>
regulations promulgated thereunder; and provided, further, that if required to
qualify the Plan under Rule 16b-3, no amendment that would
(a) materially increase the number of Shares that may be issued
under the Plan,
(b) materially modify the requirements as to eligibility for
participation in the Plan, or
(c) otherwise materially increase the benefits accruing to
participants under the Plan shall be made without the approval
of the Corporation's stockholders.
ARTICLE X COMPLIANCE WITH RULE 16b-3
It is the intention of the Corporation that the Plan comply in all respects
with Rule 16b-3 promulgated under Section 16(b) of the Exchange Act and that
Plan participants remain disinterested persons ("disinterested persons") for
purposes of administering other employee benefit plans of the Corporation and
having such other plans be exempt from Section 16 (b) of the Exchange Act.
Therefore, if any Plan provision is later found not to be in compliance with
Rule 16b-3 or if any Plan provision would disqualify Plan participants from
remaining disinterested persons, that provision shall be deemed null and void,
and in all events the Plan shall be construed in favor of its meeting the
requirements of Rule 16b-3.
